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Adventists following a plant-based diet have half the prevalence and incidence of type 2 
diabetes than nonvegetarian Adventists. This study used a quantitative, correlational 
study design to assess if there was a significant difference in type 2 diabetes prevalence 
rate between Adventists and non-Adventists preprogram, and if there were significant 
differences in biometrics between Adventists and non-Adventists with diabetes pre- and 
post-Complete Health Improvement Program (CHIP). This study incorporated the social 
ecological model for its conceptual framework and examined pre- and postprogram 
changes among Adventists (n=210; 20.1%) and non-Adventists (n=836; 79.9%) with type 
2 diabetes. It used secondary data from participants in the volunteer-delivered CHIP 
intervention from 2006 to 2012 (n=7,172), a whole foods, plant-based, vegan health 
program. Analysis showed a significant difference in the pre-CHIP diabetic state between 
the two groups in step one, but not after controlling for covariates in step two (OR=0.96 
and 0.91; CI=1.21 and 1.24). A repeated measures MANOVA analysis indicated that 
religious affiliation (Adventist or non-Adventist) was the determining factor in improved 
biometric outcomes pre- and post-CHIP for TC (F(1) = 5.65; p = 0.02), and LDL (F(1) = 
5.76; p = 0.02) but not for HDL (F(1) = 0.00; p = 0.99), TG (F(1) = 0.19, p = 0.67), FPG 
(F(1) = 2.71, p = 0.10), SBP (F(1) = 2.25; p = 0.13), DBP (F(1) = 1.20; p = 0.27), and 
BMI (F(1) = 1.65; p = 0.20). However, both groups improved post-CHIP in all 
biometrics. The implications for positive social change from this study showed that CHIP 
is an effective lifestyle model for improving type 2 diabetes outcomes for both Adventists 
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Chapter 1: Introduction to the Study 
Introduction 
The two main types of diabetes are type 1, formerly referred to as insulin- 
dependent diabetes or juvenile diabetes, and type 2, formerly referred to as adult-onset 
diabetes. Type 1 diabetes is characterized by an absolute deficiency of insulin, and type 2 
is characterized by insulin resistance and a progressive deficiency in insulin production 
(ADA, 2016). Type 1 diabetes accounts for 5-10% of all diabetes cases, and type 2 
diabetes accounts for 90-95% (ADA, 2016). In 2009, 191,986 (0.25%) youth in the 
United States aged 0 to 19 years had diabetes, with 20,262 of those youth having type 2 
(Pettitt et al., 2014); this number is expected to quadruple by 2050 (Imperatore et al., 
2012). Prevalence is significantly higher in U.S. adults: 29.1 million (9.3%) have type 2 
diabetes and 1.7 million acquire it annually (ADA, 2013). Previous research has 
suggested an association between improved glycemic control and biometrics after 
switching to a vegetarian diet (Barnard, Katcher, Jenkins, Cohen, & Turner-McGrievy, 
2009; Yokoyama, Barnard, Levin, & Watanabe, 2014). This research study focused on 
type 2 diabetes and included all ages.  
This study was specifically designed to investigate dietary and religious 
influences on diabetes treatment. Seventh-day Adventists (Adventists) who follow a 
plant-based (vegan) diet have approximately half the prevalence and incidence of 
diabetes compared to nonvegetarian Adventists and with lower rates of metabolic 
syndrome (Le & Sabate, 2014; Orlich & Fraser, 2014; Tonstad et al., 2013). Adventists 




teaching in this conservative, Protestant movement (Butler et al., 2008). This makes 
Adventists an ideal group for use in studying the relationships between diet and disease. 
Adventists show an unusual behavioral homogeneity that makes them an ideal 
comparative group. Since its conception as an organization in the 1860s, this group has 
been taught by proscription to abstain from tobacco (98.9%), alcohol (95.4%), illicit 
drugs, and caffeine; this adherence significantly reduces the confounding effects of 
nondietary factors (Butler et al., 2008). Adventists also abstain from Biblically unclean 
meats such as pork and shellfish (Leviticus 11, King James Version); although a 
vegetarian diet is not required, it is advocated within their membership (Phillips, Kuzma, 
Beeson, & Lotz, 1980). A typical Adventist diet emphasizes fruits, vegetables, whole 
grains, legumes, and nuts, while discouraging rich desserts, spices, and highly refined 
foods; members are also encouraged to exercise (Butler et al., 2008; Phillips, Kuzma, 
Beeson, & Lotz, 1980). With this consistent foundation, Adventists then have a wide 
spectrum of diets from eating meat to being total vegetarian (often referred to as vegan), 
abstaining from all animal products including eggs, dairy, and all flesh meats. Non-
Adventist research also suggests that meat consumption increases the risk of type 2 
diabetes, and by switching to a vegan or vegetarian diet (includes dairy and eggs but 
excludes animal flesh), diabetes outcomes improve (Barnard, Levin, & Trapp, 2014; 
Fung, Schulze, Manson, Willett, & Hu, 2004; Pan et al., 2013).  
This study examined the Adventist health message through the social ecological 
model (SEM; Bronfenbrenner, 1979) and how that health message has been incorporated 




Improvement Program (CHIP; formerly known as the Cardiac Health Improvement 
Project; Diehl, 1998), an Adventist-run program that has produced multiple influences at 
the individual, social, community, and institutional levels.     
CHIP is a 30-day, professional- and volunteer-delivered, video-presented, 
community-setting, plant-based, whole-food, vegan, lifestyle modification program that 
has been adopted by the Seventh-day Adventist (Adventist) church. CHIP was designed 
to improve and target those with type 2 diabetes and cardiovascular disease (Rankin et 
al., 2012). The foundational CHIP intervention was based on a number of theoretical 
frameworks, but most strongly draws on the theory of planned behavior (TPB; Ajzen, 
1985). As a result, it has a strong educational component to help people change attitudes, 
social norms, and perceived control towards leading healthier lifestyles (Morton et al., 
2014a). This dissertation, however, diverged from this earlier foundation by being based 
on the social ecological model (SEM) described by Bronfenbrenner (1979).   
The CHIP lifestyle intervention program, now referred to simply as CHIP, works 
with volunteers and professionals to deliver a video-based health program in a 
community setting (Morton, Rankin, Kent, & Dysinger, 2014a). The first 30-day CHIP 
lifestyle intervention was presented in 1988 and recorded in 1997, which allowed both 
professionals and trained CHIP volunteers to administer the program in their perspective 
and separate settings. At the time of this study, over 70,000 participants have gone 
through the program worldwide and is described in more than 25 publications (Morton et 




This present study drew on data and other information from 25 peer-reviewed 
studies on the CHIP program. Seventeen of these studies examined formally educated 
healthcare professionals who delivered the CHIP lifestyle intervention. Seven of these 
studies examined volunteers who may or may not have been medically trained. One study 
summarized the history of CHIP for both professionals and volunteers. This dissertation 
focused on the volunteer branch of the CHIP intervention. CHIP founder, Dr. Haans 
Diehl videotaped sixteen 2-hour presentations and made them available in 1997 to lay 
people (mainly Adventists) who had an interest in improving the health of people in their 
local communities (Rankin et al., 2012). Being a health professional was not a criterion 
since the program directors had only a facilitator’s role, not an educator’s role (Rankin et 
al., 2012). In these interventions, Diehl gave health education instruction via recorded 
video and volunteers directed group discussions, presented cooking demonstrations, and 
provided grocery store tours. Adventists have presented most CHIP programs.  
Earlier CHIP studies have compared mean changes pre- and postprogram in terms 
of overall participation and between genders. However, this prior research had not 
determined if there was a prevalence rate difference of self-identified type 2 diabetes 
between Adventists and non-Adventists pre-CHIP, and if having a particular religious 
belief (Adventist or non-Adventist) affected biometric outcomes (total cholesterol [TC], 
high-density lipoproteins [HDL], low-density lipoproteins [LDL], triglycerides [TG], and 
fasting plasma glucose [FPG], systolic blood pressure [SBP], diastolic blood pressure 




addressed this gap in the literature by tracking biometrics via the biomarkers TC, HDL, 
LDL, TG, and FPG, and clinical parameters of SBP, DBP, and BMI.  
Since its inception in the 1860s, the Adventist church has had a consistent, 
worldwide commitment and a rich history of positive social change by providing 
education for the prevention of disease and the relief of sickness in a variety of societal 
settings (Fraser, 2003). This study investigated some of the foundational elements of this 
social change education: giving participants the tools they needed to start and maintain a 
positive healthy lifestyle, and teaching the benefits of doing such. The study’s implication 
for positive social change consists of determining whether the Adventist health message, 
as presented through CHIP, is an effective non-medical, whole-food, plant-based, 
lifestyle model in improving type 2 diabetes outcomes for Adventists and non-Adventists 
similarly. A planned outcome was determining whether the Adventist health message is 
appropriate for use as a source of inspiration, optimism, strength, and guidance in health 
challenges for all who choose a dietary approach to diabetes prevention and reversal 
without the use of pharmaceuticals, regardless of faith belief.     
Background of the Topic 
The Adventist church has taught a progressive health reform message since its 
inception in the mid-1800s, including both a unique council on health and the founding of 
many new health-related organizations (Douglass, 1998). Adventists have published 
health literature showing a connection between lifestyle, diet, spirituality, and disease; 
they opened up their first sanitarium in 1866, the Western Health Reform Institute in 




Battle Creek Sanitarium applied the above unique health principles with successful 
patient outcomes, although the principles had not yet been validated scientifically 
(Robinson, 1943, p. 152). Since then, both Adventists and non-Adventists have started 
other similar programs that have since been scientifically validated (Fraser, 2003). 
Sanitariums, or live-in residential lifestyle programs such as Battle Creek Sanitarium, 
provide a controlled setting where participants learn to optimize their lifestyle through a 
whole-food, plant-based diet, exercise, and other healthful principles (Crane & Sample, 
1994; McDougall et al., 2014, Slavicek et al., 2008). Examples of extant lifestyle centers 
include the Weimar Institute, Uchee Pines Institute & Lifestyle Wellness Center, 
Wildwood Lifestyle Center & Hospital, Eden Valley Institute of Wellness, Pritikin 
Longevity Center, and BellaVita Lifestyle Center.    
In the mid-1950s, longitudinal studies by both Adventist and non-Adventist 
groups began to validate scientifically associations among incidence, prevalence, 
predisposing factors, and prognosis with lifestyle, diet, and disease. Some of these long-
term studies include the following:  
• the Framingham Study (Castelli et al., 1986)  
• the Nurses’ Health Study I and II, the Health Professional Follow-Up Study (Pan 
et al., 2011)  
• the Adventist Health Study 1 and 2 (Rizzo, Sabate, Jaceldo-Siegl, & Fraser, 2011; 
Tonstad, Butler, Yan, & Fraser, 2009; Tonstad et al., 2013)  
• the Adventist Mortality Study (Vang, Singh, Lee, Haddad, & Brinegar, 2008),  




• the Adventist Health Air Pollution Study (Chen et al., 2005) 
Community lifestyle programs added yet another educational dimension to 
teaching about lifestyle, while also teaching foundational health principles to prevent and 
reverse chronic disease in a stay-at-home setting. These programs are offered in a variety 
of settings: 
• in the workplace (Levin, Ferdowsian, Hoover, Green, & Barnard, 2010)  
• through local research studies (Knowler et al., 2002)  
• through randomized, controlled studies (Barnard et al., 2009a)  
• through private physician offices (Crowe, Ellis, Esselstyn, & Medendorp, 1995) 
• at hospitals and clinics (Englert, Eiehl, Greenlaw, Willich, & Aldana, 2007)  
• by faith-based groups such as CHIP (Kent et al., 2013a)   
Prior research on the CHIP intervention showed that men improved more than 
women in all biometrics except high-density lipoprotein (HDL; Kent, Morton, Rankin, 
Gobble, & Diehl, 2014). In this research, HDL dropped lower in women (7.6% versus 
9.1%), and those with the worse biometrics made the greatest improvements because they 
had the greatest amount of room to change (Kent et al., 2014). The value of monitoring 
HDL when assessing a change to a plant-based diet has been questioned since this and 
other research has observed a drop in HDL phenomenon despite overall cardiovascular 
risk improvement (Barnard, 1991; Esselstyn et al., 1995; Kent et al., 2013b; Morton et 
al., 2013; Ornish et al., 1998; Rankin et al., 2012). CHIP research has shown that the 30-
day program has had the following effects:  




• men reduced systolic blood pressure (SBP) by 5.5% and women by 5.1%  
• men reduced diastolic blood pressure (DBP) by 5.9% compared to 4.8% for 
women 
• men reduced total cholesterol (TC) by 13.2% compared to 10.1% for women  
• men reduced low-density lipoproteins (LDL) by 16.3% compared to 11.5% for 
women  
• men reduced triglycerides (TG) by 11.4% compared to 5.6% for women 
• men reduced fasting plasma glucose (FPG) by 8.2% compared to 5.3% for women 
(Kent et al., 2014; Morton et al., 2014a)  
Although CHIP is an Adventist-driven program, research has focused on 
outcomes comparing genders, and pre- and postbiometrics in general. However, the 
literature review did not identify research that compared whether coupling a certain 
religious belief with type 2 diabetes may differ in outcomes between Adventists and non-
Adventists. Until now, it was unknown if being an Adventist or non-Adventist elicited 
different biometric outcomes pre- and post-CHIP in those with type 2 diabetes, and if 
there was a difference between the incidence rate of Adventists and non-Adventists who 
have self-identified themselves as having type 2 diabetes preprogram.  
Problem Statement 
Type 2 diabetes is a national problem in the United States and globally (American 
Diabetes Association [ADA], 2015). Each year, approximately 1.7 million people in the 
United States acquire type 2 diabetes, in addition to the 29.1 million who already have 




healthcare system billions of dollars per year (ADA, 2013). Since 2002, the total U.S. 
economic cost of diabetes has risen from $132 billion (ADA, 2003) to over $245 billion 
in 2012 (ADA, 2013). Seventy percent of people with diabetes will die from 
cardiovascular disease (CVD), which includes heart disease—the number one cause of 
death and disability for those with diabetes (Zhao et al., 2014). The foundational 
treatment for diabetes and CVD is diet and lifestyle (Dinu, Abbate, Gensini, Casini, & 
Sofi, 2016); however, this has historically been given little attention compared to 
pharmaceuticals (ADA, 2015).  
CVD costs in the United States are alone projected to triple from $273 billion in 
2010 to $818 billion in 2030 (Heidenreich et al., 2011). Coronary heart disease (CHD) 
causes about 720,000 heart attacks each year, resulting in 380,000 deaths in the United 
States annually at a cost of $108.9 billion (Murphy et al., 2013). Some of the current, 
well-recognized risk factors of type 2 diabetes include the following:  
• being overweight (Biggs et al., 2010)  
• inactivity (Hu, 2003; Jeon, Lokken, Hu, & van Dam, 2007; Plotnikoff, Costigan, 
Karunamuni, & Lubans, 2013)  
• improper nutrition (Barnard et al., 2009; Pan et al., 2011; Tonstad et al., 2013)  
• high blood pressure, cholesterol, and blood sugars (Rosner et al., 2009)  
• statin medications (Mansi, Frei, Wang, & Mortensen, 2015; Macedo, Douglas, 
Smeeth, Forbes, & Ebrahim, 2014). 
The problem addressed by this study is that the current dietary recommendations 




type 2 diabetes, but instead manage it primarily through medications and moderate intake 
of all foods, regardless of their health value (ADA, 2016). A whole food, plant-based 
diet, without the use of animal products, improves blood sugar control better than 
pharmaceuticals (Knowler et al., 2002) and the standard diabetes diet (Barnard et al., 
2009) without the negative side effects of pharmaceuticals (Graham et al., 2010). 
Moreover, some foods are more problematic, like processed carbohydrates, dairy, eggs, 
fat, and animal protein (Djousse, Khawaja, & Gaziano, 2016; Hu, Pan, Malik, & Sun, 
2012; Lawlor, Ebrahim, Timpson, & Smith, 2005; Pan et al., 2013; Vitale et al., 2015), 
and others are more beneficial, like whole-plant foods and a vegan diet (Tonstad et al., 
2013, Turner-McGrievy, 2008). Those with diabetes also improve FPG by replacing red 
meat with legumes (Hosseinpour-Niazi, Mirmiran, Hedayati, & Azizi, 2014) and by 
reducing red meat consumption (Pan et al., 2013). Vegetarian and vegan Seventh-day 
Adventists have reduced incidence (Tonstad et al., 2013) and prevalence (Tonstad et al., 
2009) of diabetes and metabolic syndrome (Rizzo, Sabate, Jaceldo-Siegl, & Fraser, 
2011), suggesting that dietary content has a significant effect. Additional evidence 
supporting this includes a drop in mortality rate (Heuch, Jacobsen, & Fraser, 2005) and 
ischemic heart disease the longer Adventists have been baptized members and following 
the recommended lifestyle (Snowdon, Phillips, & Kuzma, 1982). During a 1960s 
Adventist study, members baptized as children died at 71% the risk as members baptized 
as adults, signifying that the younger members changed their lifestyle to a vegetarian diet, 




Although CHIP is an Adventist-facilitated program, a gap in the literature existed 
in relation to assessing if the CHIP lifestyle affected Adventists and non-Adventists 
differently. This current research assessed if those with a particular religious belief 
(Adventist) experienced different outcomes from the CHIP program when compared to 
those who did not hold that religious belief (non-Adventist). It was also unknown 
whether Adventists entered the CHIP program with a different prevalence rate of self-
identified diabetes. This dissertation therefore compared eight biometric outcomes pre- 
and post-CHIP in Adventists and non-Adventists with type 2 diabetes, and assessed 
whether there was a difference in the self-identified diabetes rate between Adventists and 
non-Adventists pre-CHIP.  
Purpose of the Study 
This quantitative, correlational study analyzed secondary data to assess how 
Adventist affiliation affected biometric outcomes. It specifically compared how having a 
particular religious belief (Adventist or non-Adventist) for those with type 2 diabetes 
affects eight biometric outcomes—TC, HDL, LDL, TG, FPG, SBP, DBP, and BMI—for 
pre- and post-CHIP intervention, while controlling for four covariates. It also specifically 
assessed if Adventists or non-Adventists entered the program with a statistically 
significant different rate of self-identified diabetes while controlling for five covariates. 
Prior research suggested that Adventists enter the CHIP program with improved baseline 
risk factors over non-Adventists, but non-Adventists see greater improvements because 
there was more room for improvement (Rankin, 2014). It was unknown how the 




with type 2 diabetes, although other research has revealed that religiosity can improve 
those outcomes (Eleuterio da Silva, Eleuterio da Silva, Marcilio, & Pierin, 2012). An 
examination of the research reveals limited studies comparing Adventists to non-
Adventists. 
Research Questions and Hypotheses 
The following research questions guided this study: 
Research Question 1 (RQ1):  After controlling the effects of age, gender, marital 
status, BMI, and parental death from diabetes before age 60, is there a statistically 
significant difference in self-identified type 2 diabetes prevalence rates between 
Adventist and non-Adventist CHIP participants preprogram between January 2006 and 
September 2012?  
H01: The self-identified diabetes prevalence rate between Adventist and non-
Adventist in pre-CHIP participants is not significantly different.  
H11: The self-identified diabetes prevalence rate between Adventists and non-
Adventists in pre-CHIP participants is significantly different. 
The dependent variable tracked in answering RQ1 was self-identified diabetes. 
The independent variables were religiosity and testing period. Five covariates were also 
tracked: age, gender, marital status, BMI, and parental death from diabetes before age 60. 
The quantitative test used to answer this question was logistic regression. 
Research Question 2 (RQ2):  After controlling for the effects of age, gender, 
marital status, and parental death from diabetes before age 60, is there a statistically 




SBP, DBP, and BMI) between Adventists and non-Adventists with self-identified 
diabetes pre- and post-CHIP between January 2006 and September 2012? 
H02: There is no statistically significant difference in biometric outcomes 
between Adventists and non-Adventists with self-identified type 2 diabetes pre- and post-
CHIP. 
H12: There is a statistically significant difference in biometric outcomes between 
Adventists and non-Adventists with self-identified type 2 diabetes pre- and post-CHIP. 
The dependent variables tracked in answering RQ2 were TC, HDL, LDL, TG, 
FPG, SBP, DBP, and BMI. The independent variables were religiosity and testing period. 
The covariates were age, gender, marital status, and parental death from diabetes before 
age 60. The quantitative test used to answer RQ2 was a multiple analysis of variance 
(MANOVA). 
Conceptual Framework for This Study 
The conceptual framework for this research was based on the social ecological 
model (SEM) developed in the late 1970s by Urie Bronfenbrenner. SEM was initially 
developed to understand the factors that influenced and prevented violence in child abuse 
(Bronfenbrenner, 1979). The SEM is now used to explain the interconnectedness and 
often complex and evolving associations among society, community, interpersonal 
relationships, and individuals (Bronfenbrenner, 1994). In the initial model, these four 
associations were in a nested structure, each inside the other with the innermost position 
containing the individual. Moving outward, the next position was interpersonal 




systems way of looking at human behavior in which each level is often fluid and 
interactive with other levels. To make large societal changes, SEM suggests 
understanding the problem from each social level, then affecting each level appropriately 
through educational efforts. As each social level creates its own change, it affects all the 
other levels interchangeably.    
For example, the initial SEM (Bronfenbrenner, 1979) instituted to explain abuse. 
The first or innermost level identified individual settings or characteristics that affect 
abuse, which may be, for example, in the home environment or classroom setting, and 
included being either the perpetrator or victim. Factors that influenced abuse included age 
of the child, stress level, family history of abuse, substance abuse, having a rigid belief 
system, and limited educational attainment (Dahlberg & Krug, 2002). In a preventative 
approach at the individual level, the educational outreach approach may include targeting 
and training for childcare staff, pediatricians, schoolteachers, and counselors.  
The second layer out, next to the individual position, is interpersonal 
relationships, which looks at the interconnectedness between environments and 
relationships among those within the closest social circle (Krug, Mercy, Dahlberg, & 
Zwi, 2002). This level looked at family members, peers, and partners who have influence 
in the environment. In a preventative approach at the interpersonal relationship level, 
education may include mentoring and peer programs to improve problem-solving skills 
and parenting skills, as well as reducing seclusion.      
The third level takes a broader view yet by looking at the outward community 




relationships occur and abuses happen. In a preventative approach, the strategies targeted 
changing the climate of these places, including after-school programs, recreation center 
activities, and family fun nights (Bronfenbrenner, 1979). Focusing on community settings 
fosters safer neighborhoods, schools, and communities. 
The outermost or fourth level looks at the society at large, creating a broader 
influence that inhibited abuse through cultural and social norms (Krug et al., 2002). 
Societal strategies included targeting social media, health and education policies, social 
and economic policies, and social norm campaigns. Focusing on the societal level 
changes the way the public thinks, and when facing a particular situation, society would 
ideally take a more positive approach. Each of the four influential levels of society work 
together to create change, individuals learn new norms in every social level.   
Since the time of the original model, Bronfenbrenner (Bronfenbrenner, 1994) and 
others (Attorney General’s Sexual Assault Task Force, 2006; Golden, McLeroy, Green, 
Earp, & Lieberman, 2015) have continued to modify, update, and revise the SEM. It now 
includes institutions as a fifth social influence, and nestles it in between community and 
societal as its new fourth layer, with societal being bumped out to the fifth level. 
Realizing that institutional processes also play a role in social influence and behavior 
change—such as anti-bullying programs, strict anti-abuse laws, zero tolerance policies, 
group home rules and staff training, media education, and guidelines for reporting 
abuse—this additional social layer was also added. The SEM attempts to explain human 
behavior as it relates to the interrelationships among each social influence and recurring 




which views the person and the differing social environments as interlinking influences 
(Raingruber, 2014, p. 64). 
  Given the complexity of a comprehensive, multilevel, health promotion 
intervention, it is essential to consider the individual, relational, community, institutional, 
and societal impacts that influence and sway health outcomes. Targeting one specific 
social level about health would not be as effective as simultaneously concentrating on 
multiple health factors considering healthy and unhealthy lifestyle principles come from 
each social level in reciprocal influences (Raingruber, 2014, p. 64). The SEM assumes 
people are more likely to succeed when multiple supportive social environments are 
activated, cumulative, and combined, which all influence, shape, and support one other. 
The dissemination of the Adventist health message has taken similar shape, reaching 
every sector of society, with CHIP intersecting three of those levels. See Figure 1. 
At its inception in the 1860’s, the Adventist church’s foundation was built upon 
the biblical mandates of Matthew 28:19-20 and Revelation 14:6-12 to go into all the 
world to proclaim the gospel. Adventists believe that the gospel message includes the 
responsibility to care for their body, which has guided much of their outreach (1 
Corinthians 3:16; 2 Corinthians 6:16; 3 John 2; Romans 12:1-2; Seventh-day Adventist 
World Church, 2016). The church has embraced its signature health message following 
the example of Jesus to relieve suffering (Matthew 15:29-31), believing there is a 
connection between healthful living, a clear mind, a healthy body, and true worship 




With its unique vision of promoting health in all sectors of society, the Adventist 
health message has naturally fit into the SEM model. CHIP takes shape within the 
community setting but also influences the relationship-building and individual 
environments in society. CHIP is one educational piece within the entire Adventist 
Health Message. At an individual level, health reform is encouraged by the church 
(General Conference of Seventh-day Adventists, 2010, p. 91; White, 1948, 9T, p. 158) 
through personal Bible study, reading healthful living books penned by Ellen G. White, 
and in keeping up to date with current day research that still fits into the Adventist health 
principles foundation. It is from these sources that knowledge, skills, attitudes, and CHIP 
principles are learned and encouraged. In that inner social sphere, each CHIP participant 
makes the necessary healthful changes they learned throughout the program to improve 
their TC, HDL, LDL, TG, FPG, BMI, SBP, and DBP. In order to investigate the 
intersection of religion and health, this dissertation also included the covariates of age, 
gender, marital status, BMI, and parental death from diabetes before age 60, since each 
one has been shown to be a factor in diabetes development.   
In the second outer social sphere, relationship building, or social networking, 
friends, family, and church groups model the Adventist health message and CHIP’s 
healthful teachings to one another, where people learn new social norms through the local 
church via health sermons, bulletin inserts often termed health nuggets, and small support 
groups such as CHIP (General Conference of Seventh-day Adventists, 2010, p. 26-27, 
139-140). In the third social sphere, community influence, the Adventist church offers 




ministry health outreach, plant-based, vegan cooking classes, and stop-smoking, 
depression, and stress-control programs (General Conference of Seventh-day Adventists, 
2010, p. 91; White, 1948, 9T, p. 112).  
The fourth and more broad social sphere, institutional influences, includes the 
Adventist Development & Relief Agency (ADRA) for disaster relief and health 
dissemination, publishing agencies, and Adventist Book Centers where a host of 
literature may be purchased (General Conference of Seventh-day Adventists). The fifth 
and most outer social sphere contains the societal influences the Adventist church uses as 
its broadest form of health education and outreach, and includes worldwide Adventist 
television and satellite with their health programs, the Blue Zone, the Adventist health 
studies as published research, and the worldwide Adventist health care system (White, 
1938, p. 75).  
Within the multifaceted social ecological model, the Adventist health message 
touches each level of the social sphere from personal to relational, community, 
institutional, and societal, with CHIP influencing many levels. Each social sphere is 
influenced by the next, and the environment is continually being shaped depending on 
whom each one meets and learns from (Raingruber, 2014, p. 65). One does not have to be 
a member of the Adventist church to be influenced by one or more of the many levels of 
the church’s health message. The majority of the CHIP participants are non-members, 








































Figure 1. Societal influences of the Adventist health message depicted through the social 
ecological model.    
Knowledge, skills, attitudes, & 
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Nature of the Study 
The nature of this study was a quantitative, correlation research design, which 
used secondary data excluding identification markers, having received permission from 
CHIP researchers to share their data for the purpose of this dissertation. Data was 
collected from 241 programs from 163 sites, between January 2006 and September 2012, 
involving 7,172 individuals. Volunteer directors underwent a 2-day training seminar to 
receive training manuals, program content, and instruction on how to deliver the sixteen 
2-hour group sessions. Program content included its philosophy and methods and how to 
lead cooking classes, grocery store tours, group discussions, and exercise classes, and the 
prerecorded video education. Video instruction included education on a plant-based diet, 
exercise, behavioral change, self-worth, modern medicine’s strengths and weaknesses, 
smoking, cholesterol, fiber, lifestyle and health, and epidemiology and risk factors of 
CVD, type 2 diabetes, atherosclerosis, hypertension, obesity, and dyslipidemia.  
Pre- and post-CHIP measurements included blood samples for TC, HDL, LDL, 
TG, and FPG, and height and weight for BMI, and blood pressure (BP), and were the 
variables for this study. The dependent variable in RQ1 were self-identified diabetes, and 
the independent variables were religiosity and testing period. The covariates were age, 
gender, marital status, BMI, and parental death from diabetes before age 60. The 
dependent variables in RQ2 were TC, HDL, LDL, TG, FPG, SBP, DBP, and BMI, with 
religiosity and testing period as independent variables. The covariates were age, gender, 
marital status, and parental death from diabetes before age 60. Diet, race, income, and 




who attended 13 of 16 sessions and completed a self-reported medical, lifestyle pre-
questionnaire and pre- and postassessments were defined as graduated and included in 
this study.  
A quantitative correlational research design was chosen for this research since it 
provided valuable data for looking at relationships between variables, with the intent to 
generalize findings from a sample to a population (Creswell, 2009), testing the impact of 
the interventional CHIP program on a specified group of people. The variables were 
measured using the statistical analysis of MANOVA and regression analysis. The final 
report was controlled for confounders, protected against biases, and reproducible and 
generalizable to the population. Traditionally, quantitative designs provide reliability, 
objectivity, as well as internal and external validity (Trochim & Donnelly, 2008). 
Operational Definitions 
Body mass index (BMI): A measurement of body fat in relation to weight and 
height. BMI is calculated by dividing weight in kilograms by height in meters squared. 
BMI is a screening tool to categorize weight from underweight, normal weight, 
overweight, to categories of obesity (Garrow & Webster, 1984). CHIP used the World 
Health Organization (WHO) BMI categories, measured as kg/m² (Alberti & Zimmet, 
1998). A normal BMI is 18.5 to 24.9 kg/m². 
Complete Health Improvement Program (CHIP): A 30-day intensive, 
community-based, plant-based, video-delivered, comprehensive health education, and 




Diastolic blood pressure (DBP): The bottom number of the two numbers 
recorded when the blood pressure is taken. It is the relaxation phase of the heart after 
pressure has been placed against the wall of the blood vessel, and blood fills the heart 
again. CHIP used the NCEP Treatment Panel III classification system to categorize DBP, 
measured in mmHg (NCEP, 2002). A normal diastolic pressure is <80 mmHg. 
Fasting plasma glucose (FPG): A measurement of blood sugar without caloric 
intake for at least eight hours. CHIP used the Treatment Panel III classification system to 
categorize FPG, measured in mg/dL (NCEP, 2002). A normal FPG for this study is 
considered <110 mg/dl. 
Graduate: In the context of this study, a CHIP participant who attended 13 of 16 
CHIP sessions, completed a self-reported medical and lifestyle prequestionnaire, and 
completed pre- and postassessment questionnaire (Kent et al., 2014). 
High-density lipoproteins (HDL): A carrier of cholesterol through the blood 
stream, typically thought of as good cholesterol. CHIP used the National Cholesterol 
Education Program (NCEP) Treatment Panel III classification system to categorize HDL, 
LDL, and TG, measured in mg/dL (NCEP, 2002). A normal HDL is 40-60 mg/dl. 
Low-density lipoproteins (LDL): A carrier of cholesterol through the bloodstream, 
typically thought of as bad cholesterol. CHIP used the NCEP Treatment Panel III 
classification system to categorize HDL, LDL, and TG, measured in mg/dL (NCEP, 




Plant-based diet: A diet based upon fruits, vegetables, whole grains, legumes, and 
nuts, without the use of animal products. Referred to as the Optimal Diet in CHIP 
(Englert et al., 2004). Often also called a vegan or total vegetarian diet. 
Professionally-delivered: In the context of this study, a term to describe a delivery 
of the CHIP program in a workplace or clinical setting by formally trained and educated 
health professionals (Morton et al., 2014a). 
Self-selected: CHIP participants choosing to participate in the health education 
program and paid for this service (Diehl, 1998). 
Seventh-day Adventist (Adventist): A member of a conservative, Protestant, 
worldwide, and growing body of about 18 million members with a worldwide focus on 
health and health outreach (Seventh-day Adventist World Church (SDAWCH), 2015a).  
Systolic blood pressure (SBP): The top number of the two numbers recorded 
when the blood pressure is taken. It is the pressure phase exerted on the blood vessel 
walls as the heart constricts, pushing blood out of the heart into the body. CHIP used the 
NCEP Treatment Panel III classification system to categorize SBP, measured as mmHg 
(NCEP, 2002). A normal SBP is <120 mmHg.   
Total cholesterol (TC): A blood test result showing the sum total of circulating 
LDL, HDL, and very low-density lipoprotein (VLDL). CHIP used the Framingham Risk 
Classification for stratifying TC, measured in mg/dL (Wilson et al., 1998). A normal TC 




Triglycerides (TG): A form of fat in blood. CHIP used the NCEP Treatment Panel 
III classification system to categorize TG, measured in mg/dL (NCEP, 2002). A normal 
TG is <150 mg/dl.  
Type 2 diabetes: A metabolic disorder with glucose inefficiency coupled with 
overproduction (Sacks et al., 2011). A diagnosis of diabetes requires a FPG of >125 
mg/dL on two separate occasions (ADA, 2016) 
Volunteer-delivered: In the context of this study, a term to describe delivery of the 
CHIP program by facilitators mainly sourced from the Adventist church who wanted to 
positively affect their community. Facilitators participating in volunteer-delivered 
services required no special formal education, they instead attended a 2-day training 
seminar to develop facilitator skills and receive certification (Kent et al., 2014). 
Assumptions 
A plant-based diet is typically lower in calories, fat, trans fats, cholesterol, and the 
glycemic index, as well as being higher in fiber and nutrient density than the typical 
American diet (Barnard et al., 2009b; Levin et al., 2010) and the diet set forth by the 
American Diabetes Association (ADA; Barnard et al., 2009a). My assumption was that as 
individuals with diabetes from both faith groups switch from the standard American diet 
(SAD) to a plant-based diet, both would see improvements in their biometric outcomes, 
but it was unknown as to whether one group would outperform the other due to their faith 
group. Those on a vegan diet develop diabetes at a rate of 0.54%, which is significantly 




Similarly, the prevalence of diabetes incrementally reduces as the diet changes from 
meat-based (7.6%) to vegan (2.9%) (Tonstad et al., 2009). 
A second assumption was that those who self-identified “have you ever been told 
by a doctor you have diabetes” were referring to type 2 diabetes. This was a reasonable 
assumption because 90-95% of those with diabetes have type 2 (ADA, 2016). When a 
clarification of the word “diabetes” is not given, the assumption is normally that it refers 
to type 2. In addition, it is assumed type 2 since CHIP targets individuals with type 2, not 
another. If CHIP participants had asked for clarification as to which type of diabetes was 
meant on the pre-assessment questionnaire, they would have been told type 2. Lastly, 
those with type 1 or 1.5 diabetes are often not attracted to lifestyle programs since those 
types of diabetes are less associated with lifestyle and considered a progressive, lifetime 
condition (ADA, 2016).  
It is also assumed that all who stated they had diabetes, actually had it and that 
those who did not mark it, did not have the disease. It is possible that some people who 
had diabetes did not know it, and therefore did not mark the box. Others may have simply 
not marked the box though they had diabetes. Lastly, it is assumed that all the biometrics 
were input into the CHIP database correctly by each location director, and that the 
database supplied was correct.    
Many extant studies demonstrate that there are improvements in the symptoms of 
type 2 diabetes when switching to a plant-based diet that excludes all animal products. 
Many studies compare Adventists to other Adventists with different eating patterns, but 




diabetes and their effects of switching to a plant-based CHIP diet while implementing 
CHIP. A gap in the literature existed when it comes to assessing if a particular religious 
belief system has an influence on biometric outcomes on those with diabetes. 
Scope and Delimitations of the Study 
This study design included data from 7,172 self-selected participants who had 
participated in 241 CHIP programs given at 163 sites from Canada and the United States 
between January 2006 and September 2012. Participants were taught and prescribed a 
whole-food, plant-based diet and other healthful lifestyle principles as the intervention to 
improve chronic disease biometric outcomes. Programs were facilitated mainly by 
Seventh-day Adventist volunteers after having attended a two-day instruction workshop 
and given all required materials to facilitate the program. The foundational treatment for 
type 2 diabetes is diet and lifestyle (ADA, 2016), but literature gives little attention to 
diet and lifestyle in comparison, and more attention is paid to pharmaceuticals, despite 
their greater negative potential side effects over dietary changes (Graham et al., 2010; 
Kannan et al., 2016; Lincoff, Wolski, Nicholls, & Nissen, 2007; Solomon & 
Winkelmayer, 2007). CHIP addresses the root cause of diabetes through improving the 
diet and lifestyle, which also reduces the risk of metabolic syndrome (Rankin, 2013; 
Rankin et al., 2012; Morton et al., 2014b).   
The only requirements for participants of the volunteer-delivered study was the 
ability to pay $200-$250 for the course, attend at least 13 of 16 sessions, complete a self-
reported medical questionnaire and a baseline and postintervention lifestyle 




ages were included. Participants were encouraged to join the post-CHIP support group 
for further education, reinforcement, and support, but this was not a requirement. 
The CHIP intervention is based on a number of theoretical frameworks, which 
included the health belief model (HBM), the social cognitive theory (SCT), and the 
transtheoretical model (TM). However, its foundational support comes from the theory of 
planned behavior (TPB; Morton et al., 2014a), a model based upon changing attitudes of 
healthy living, fostering social norms, and increasing self-efficacy (Ajzen, 2011). 
Because of these strong educational components having been incorporated into the CHIP 
intervention, health literacy, accountability, and perceived control improve post-CHIP 
biometrics (Aldana et al., 2005). These frameworks are not investigated further in this 
present study. 
Limitations 
Limitations are an intrinsic part of all research, which may affect the validity, and 
is therefore necessary to reflect on and recognize and eliminate them in future research; 
several limitations are outlined here.  
1) CHIP does not have a control group in which to compare outcomes. However, 
the Rockford CHIP has published research using randomized clinical control trials with 
results for the professional programs showing similar outcomes as the volunteer branch 
(Aldana et al., 2005a; Aldana et al., 2005b; Merrill, Taylor, & Aldana, 2008).  
2) Participants attending CHIP were self-selected and therefore may be more 
motivated, ready, and willing to make the necessary changes to a plant-based diet. In the 




precontemplation and contemplation stages and were in the preparation phase, where they 
were already taking the steps to make changes (Bartholomew, Parcel, Kok, & Gottieb, 
2006, p. 110-113).  
3) Participants were self-identified when asked on the lifestyle evaluation, “have 
you ever been told by a doctor you have diabetes"; verification was not requested. It is 
possible that those with gestational diabetes, type 1 or 1.5 may have been included, but 
there is no way to know. Considering that 90-95% of people who have diabetes, have 
type 2 (ADA, 2016), the number of other types of diabetes would have been very 
negligible. Had others been included, it would have only diluted the final results.  
4) A diet diary and exercise log was not obtained from participants, so it was 
unknown as to how much change or adherence there was to the diet and exercise, and the 
effects those changes had on the biometrics. However, considering the positive outcomes 
and assuming that all participants did not fully adapt the diet, less adherence would have 
diluted the outcomes, and had there been more compliance, it would have strengthened 
the outcomes. 
5) An accurate medication diary was not obtained from participants throughout 
the CHIP intervention, though participants informed facilitators that they had either 
reduced or removed their medications by doctors order (Rankin et al., 2012). Again, had 
this data been gathered, the net cause would have created a diluted effect.  
6) Data was input into the CHIP online databank by the local facilitators, and it is 




at 163 sites throughout North America, it is unlikely, considering all the CHIP programs, 
whether volunteer- or professional-facilitated programs, had similar outcomes. 
Because this was a secondary study, further limitations and biases were minimal, 
since the trial planning and trial implementation had already occurred. Bias can occur 
during the planning phase of research, data collection, analysis, and publication 
(Pannucci & Wilkins, 2010). Biased language (Rudestam & Newton, 2007) has been 
eliminated. Known and available confounders were controlled for. 
Significance of the Study 
The results of this research made an original contribution to the literature by 
assessing how a particular religious belief affected biometric outcomes in CHIP 
participants with type 2 diabetes. The results of this study answered if the established 
CHIP lifestyle education program was equally beneficial for Adventists and non-
Adventists alike for those with diabetes. Adventists are known for their healthful, 
baseline lifestyles and reduction in diabetes over their non-Adventist counterparts 
(Alexander, Lockwood, Harris, & Melby, 1999; Fonnebo, 1992). By giving all 
participants the tools they need to start and maintain a positive healthy lifestyle and 
teaching its benefits, the positive social change from this study showed that the Adventist 
health message, as presented through CHIP, is an effective non-medical, whole-food, 
plant-based, lifestyle model in improving type 2 diabetes outcomes for all people, 
regardless of their Adventist status. The Adventist health message is a source of 




to control, prevent, or reverse this disease through a non-medical, nonpharmaceutical 
lifestyle approach. 
Summary 
Chapter 1 introduced the health challenges and the financial impact of type 2 
diabetes in the United States and its association with a nonvegetarian diet. A diet 
consisting of whole plant foods reduce the risk of diabetes while animal products increase 
the risk, and as the diet moves more towards vegan, the lower the risk of diabetes 
(Tonstad et al., 2013). As a plant-based program, the CHIP community program given by 
Adventists has the potential of influencing large numbers of people, and when 
incorporated, reduces risk factors for chronic disease (Rankin et al., 2012).  
This research incorporated the social ecological model (Bronfenbrenner, 1979) to 
explain the influence, interconnectedness, fluidity, and complex associations that occur 
among and between the social groups: individual, interpersonal relationships, the 
community, organizations, and the society at large. This study assessed if there was a 
statistically significant difference in the change in biometric outcomes (TC, HDL, LDL, 
TG, FPG, SBP, DBP, and BMI) between Adventists and non-Adventists with self-
identified diabetes pre- and post-CHIP between January 2006 and September 2012. It 
also assessed if there was a statistically different self-identified diabetes prevalence rate 
in Adventists and non-Adventists preprogram. The nature of this study was a quantitative 
secondary data analysis collected from 241 program sites between 2006 and 2012 
involving 7,172 graduates. The knowledge gap and potential contribution has been 




nonmedical, whole-food, plant-based, lifestyle model in improving type 2 diabetes and 






Chapter 2: Literature Review 
Introduction 
Type 2 diabetes and its precursor, prediabetes, have substantial implications for 
general and individual overall health and life expectancies, U.S. federal and state health 
care costs, household budgets, and employer costs. By 2020, an estimated 52% of the 
United States adult population will have either prediabetes or diabetes, up from 40% in 
2010 (United Health Center for Health Reform & Modernization, 2010). At the time of 
this study, diabetes was the seventh leading cause of death in the United States (CDC, 
2013a).  
Type 2 diabetes has significant financial and medical costs. Persons with diabetes 
on average spend 2.3 times more money on healthcare and have 2.9 times more doctor 
visits than their counterparts who do not have diabetes (Dall et al., 2010). Persons with 
diabetes also require more hospital admissions, home health visits, emergency room 
services, prescription drugs, medical supply needs, and use of nursing homes (Dall et al., 
2008). Over 81% of people with diabetes take some kind of diabetes medication (CDC, 
2013b). They also lose between 3.3 and 18.7 years of life, while incurring higher lifetime 
health care costs, from $8,946 to $159,380 more, depending on age at diagnosis, 
ethnicity, and gender (Leung, Pollack, Colditz, & Chang, 2015).  
Many studies have shown lifestyle approaches to be cost-effective (Eriksson et 
al., 2010; Jacobs-van der Bruggen et al., 2009) while reducing medication use (Englert, 
Diehl, Greenlaw, & Aldana, 2012). Several lifestyle programs exist that address 




Program (CHIP; Diehl, 1998), the focus of this study. CHIP is a multifactorial lifestyle 
educational program focused on diet, exercise, and stress reduction for the purpose of 
improving health outcomes for chronic diseases including diabetes, coronary artery 
disease (CAD), and hypertension (Diehl, 1998; Rankin et al., 2012). CHIP was initially 
based on the theory of planned behavior, and as a result included a strong educational 
component designed to improve health attitudes, promote healthy social norms through 
support groups, and improve perceived control through self-efficacy (Kent et al., 2014).     
Literature Search Strategy 
The literature search for this dissertation was a comprehensive search using 
Walden University’s online library system to identify articles, using the following 
databases: Academic Search Complete, PubMed, and CINAHL & MEDLINE 
Simultaneous Search. Search terms included key words with no limit in years and found 
anywhere in the text, title, or abstract of the article. The journal articles were peer-
reviewed and reviewed in either full text or abstract format. The following keyword 
searches yielded highly variable results: Complete Health Improvement Program (8), 
Coronary Health Improvement Project (46), Adventist (3,929), type 2 diabetes and vegan 
diet (235), vegetarian diet (909), type 2 diabetes and lifestyle medicine (82), Hans Diehl 
(86), D. Ornish (120), Pritikin (10), and lifestyle intervention and diabetes (5,614). Other 
articles were found using the snowball effect, and through informal conversations with 
researchers to locate articles that were in-press but had not yet been published. The article 
selection excluded research on institutionalized subjects and women with gestational 





This study used the Social Ecological Model (SEM) framework to evaluate the 
effect of the Adventist health message as taught through the CHIP intervention. The SEM 
was designed to promote health by focusing on the social accumulated effects of five 
social influence levels (Raingruber, 2014): interpersonal relationships, intrapersonal 
relationships, community, institution, and societal influences, all of which have a 
combined and cumulative effect on an individual. People succeed by having a supportive 
social environment at every level; the model assumes that each social environment 
influences human behavior accumulatively.   
SEM has been used in a variety of public health settings, with the most notable 
ones being Mothers Against Drunk Driving (MADD) and Students Against Driving 
Drunk (SADD; DeJong et al., 1998). Over a period of 25 years, MADD changed an 
entire country’s perception about drunk driving by targeting individuals and peer-related 
relationships, forming community chapters, pressuring lawmakers to pass tough criminal 
laws, and using media to reinforce their message (DeJong et al., 1998). Intervening on 
behalf of a drunken person and choosing a designated driver have both become socially 
acceptable messages (DeJong et al., 1998). The SEM has also been used to assess 
drinking patterns in a variety of settings, from home to bars, pubs, restaurants, and 
friend’s or relative’s home,  as well as appraising the impulse to drink more (Gruenewald, 
Remer, & LaScala, 2014).  
Schwartz, Tuchman, Hobbie, and Ginsberg (2011) broadened the traditional 




transition easier into adult health care. The new model incorporates pre-existing 
constructs, such as health care access, sociodemographics, medical status and risk, and 
IQ, as well as modifiable subjective variables, such as knowledge, goals, beliefs and 
expectations, skills and efficacy, relationships, and psychosocial functioning of all 
stakeholders involved (the patient, providers, and parents). This inclusion of additional 
stakeholders was intended to facilitate other clinicians and investigators building 
evidence-based evaluation tools to help make an optimal transition for chronically ill 
young adults. 
The SEM has also been used for several other contexts. Dunn, Kalich, Henning, 
and Fedrizzi (2015) used focus groups based on the five social levels of the SEM to 
understand the multifaceted barriers and contributing factors for breastfeeding in low-
income women. Barriers at each social level were then turned into educational 
opportunities to support breastfeeding, which ranged from teaching new mothers and 
family the importance of breastfeeding, to placing a baby-friendly hospital initiative, to 
implementing new workplace policies. Baral, Logie, Grosso, Wirtz, and Beyrer (2013) 
used the five social levels of the SEM to characterize the multilevel risks of HIV 
infection, turning each risk level into an evidence-based behavioral and structural 
intervention. As is characteristic of the SEM, each social level was found to be fluid and 





Type 2 Diabetes 
Diabetes is a chronic, progressive disease characterized by high blood sugars 
caused by either a lack of insulin or inefficient use of the insulin by the body (ADA, 
2016). The most common form of diabetes is type 2, which traditionally occurred in older 
people but now has been found to occur in younger people of any age (ADA, 2016). 
Approximately 29.1 million people in the United States already have type 2 diabetes; 
approximately 1.7 million people in the United States acquire the disease annually (ADA, 
2013). Type 2 diabetes kills almost 74,000 people annually in the United States and costs 
the U.S. national healthcare system billions of dollars per year (ADA, 2013).  
Since 2002, the annual total economic cost of diabetes in the United States has 
risen from $132 billion (ADA, 2003) to over $245 billion in 2012 (ADA, 2013). Seventy 
percent of people with diabetes will die from cardiovascular disease (CVD), which 
includes heart disease, their number one cause of death and disability (Zhao et al., 2014). 
CVD costs are projected to triple from $273 billion in 2010 to $818 billion in 2030 
(Heidenreich et al., 2011). Coronary heart disease (CHD) takes the life of 380,000 people 
annually at a cost of $108.9 billion, causing about 720,000 heart attacks each year 
(Murphy, Xu, & Kochanek, 2013).  
Some of the current, well-recognized risk factors of type 2 diabetes include the 
following: 




• inactivity (Hu, 2003; Jeon, Lokken, Hu, & van Dam, 2007; Plotnikoff, 
Costigan, Karunamuni, & Lubans, 2013)  
• improper nutrition (Barnard et al., 2009a; Pan et al., 2011; Tonstad et al., 
2013) 
• high blood pressure, cholesterol, and blood sugars (ADA, 2016) 
Complications of diabetes include cardiovascular disease, albuminuria, 
hypertension, dyslipidemia, poor healing, retinopathy, neuropathy, erectile dysfunction, 
peripheral artery disease, and foot complications (ADA, 2016). Major risk factors for 
type 2 diabetes includes ethnicity, being 45 years old and older, having a BMI of 25 
kg/m² or greater, and being on certain medications (ADA, 2016). Diabetes and its 
complications are both considered insidious and progressive by Western medicine 
standards (ADA, 2016), and treatments include limited lifestyle education, oral 
medications, and insulin (ADA, 2016). However, on a plant-based, whole-food diet 
without the use of animal products, and exercise, this disease can be reversed and 
prevented (Le & Sabate, 2014).  
The precursor to diabetes is the metabolic syndrome, a cluster of symptoms 
related to an increased risk of CVD, microvascular complications, and stroke (ADA, 
2016). CVD is accompanied by hypertension and dyslipidemia, and it is the major 
morbidity and mortality event contributing to the high costs of diabetes treatment (ADA, 
2013). Metabolic syndrome is characterized as having three of five risk factors according 
to the “harmonized definition” as set forth in 2009 by a joint effort among the 




National Heart, Lung, and Blood Institute; the American Heart Association; the World 
Heart Federation; the International Atherosclerosis Society; and the International 
Association for the study of Obesity (Alberti et al., 2009). These interrelated risk factors 
include central obesity, hypertension, raised TG, low HDL, and dysglycemia. These 
factors occur together routinely and are present in most people with type 2 diabetes.   
The harmonized definition for the criteria diagnosing metabolic syndrome 
includes the following: 
1) Elevated waist circumference that is population and country specific 
2) TG ≥150 mg/dL (1.7 mmol/L) 
3) HDL <40 mg/dL (1.0 mmol/L) for males and <50mg/dL (1.3 mmol/L) for 
females 
4) SBP ≥130 and/or DBP ≥85 mmHg 
5) FPG ≥100 mg/dL 
In order to categorize these and all data variables, CHIP used the conventional 
risk factor categories set up by the NCEP Adult Treatment Panel III classification system 
(Panel, NCEPNE, 2002) except for TC, for which it used the Framingham risk 
classification (Wilson et al., 1998). The Framingham risk classification allowed for five 
categories of classification, and a more detailed analysis, instead of three categories that 
the NCEP used (Rankin et al., 2012). Classifications for each biometric for this current 
research are categorized as listed: 
TC (mg/dL): <160; 160-199; 200-239; 240-280; >280 




LDL (mg/dL): <100; 100-129; 130-159; 160-190; >190 
TG (mg/dL): <100; 100-199; 200-500; >500 
FPG (mg/dL): <110; 110-125; >125 
SBP (mm Hg): <120; 120-139; 140-160; >160 
DBP (mm Hg): <80; 80-89; 90-100; >100 
BMI (kg/m²): <18.5; 18.5-24.9; 25-30; >30 
Early Health History 
Health reformers point out that a healthy, active lifestyle and a plant-based diet 
have been around for millennia; these are not new concepts or fads in disease prevention, 
as many believe (Sabate, Ratzin-Turner, & Brown, 2001). Plant-based diets and timeless 
lifestyle principles have been intuitively taught and prescribed since the time of 
Hippocrates, and later studied for their effectiveness; they continue to be researched 
today (Schwarz & Greenleaf, 2000). Hippocrates (460 BC-370 BC) was a Greek 
physician known as the “father of modern medicine,” and his timeless Hippocratic Oath 
articulates the medical ethos of “do no harm.” Historically, this has been an oath taken by 
physicians (Copland, trans. 1825; Karagiannis, 2014). In addition, Hippocrates is known 
for his proverb, “let food be thy medicine and thy medicine be thy food.” He understood 
and taught the connection between disease and lifestyle, the causation of illness, and 
ageless principles of health as written throughout the Hippocratic corpus (Karagiannis, 
2014). Another well-known, early health reformer was Sylvester Graham, a Presbyterian 
minister, best known for his creation of coarse graham bread and the graham cracker, all 




1835, 1837). He also emphasized vegetarianism, the elimination of tea and coffee, and 
abstinence in order to properly nourish the body for disease prevention (Wendell, 1835).   
Comprehensive health reform contemporaries to Graham were William Alcott, 
who founded The American Vegetarian Society (Robinson, 1965), and Joseph Bates, a 
seaman and early pioneer of the Seventh-day Adventist movement in 1839. He organized 
a temperance society and advocated for discarding coffee, tea, meat, butter, cheese, pies, 
and rich cakes in order to preserve health and prevent disease. John Harvey Kellogg, 
another early Adventist health reformer most notably known for his Kellogg’s breakfast 
cereal, advocated for coffee and tea substitutes, vegetarian health reform (Robinson, 
1965), and tobacco cessation (Kellogg, 2002). He also helped start holistic Battle Creek 
Sanitarium where he became the chief physician in 1876 under the encouragement of 
Ellen G. White, another early Adventist pioneer who progressively began to understand 
the connection between mind, body, health, diet, and worship (Robinson, 1965).   
Beginning in 1863, White became the most outspoken Adventist health reformer, 
advocating for not only a vegetarian diet and abstinence in coffee, tea, alcohol, and 
tobacco, but advanced the health reform cause by encouraging a plain, wholesome 2-
meals per day diet that eliminated swine flesh. White also advocated dress reform, 
exercise, cleanliness of self and surroundings, trust in God, fresh air, proper nightly and 
weekly rest, moderate sunshine, and water as treatment modalities over medications 
(Robinson, 1965; Schwarz & Greenleaf, 2000). White, who claimed her knowledge came 




millions worldwide on a variety of important topics, all with only a third-grade education 
(White, 2000). Her work is discussed in further detail later. 
Since the startup of Battle Creek Sanitarium, other non-Adventist current-day 
health reformers validate these health principles, such as Nathan Pritikin, founder of the 
Pritikin Longevity Research Institute in 1976, and John A. McDougall, founder of 
McDougall’s Health & Medical Center in 2002, have incorporated into their own practice 
health principles similar to the ones espoused by Ellen White. Pritikin, an engineer and 
inventor, was found to have heart disease at 40 years old but reversed it through a very 
low-fat, high-fiber, low-cholesterol, mainly plant-based diet and exercise, and then 
marketed it to others through his own program (Morton et al., 2014a). An autopsy upon 
Pritikin’s death 27 years later showed no signs of heart disease (Hubbard, Inkeles, & 
Barnard, 1985). While working at Pritikin’s residential center, and seeing cost as a 
limitation for attendees, Hans Diehl became inspired to start the CHIP program, the 
program of focus for this current research. This Adventist-facilitated program cost less, 
and participants did not have to leave home, making it well accepted and attended 
(Morton et al., 2014b). 
Over 100 research articles have been published on the Pritikin diet. Pritikin’s 
research revealed that the diet led to a 37% reduction in meeting metabolic syndrome 
criteria, a 3% BMI reduction, a 12-15% reduction in FPG and LDL respectively, a 15% 
reduction in TC, a 36% reduction in TG, and a 3% reduction in HDL after a 12-15 day 
residential stay (Sullivan & Klein, 2006). The limitations in this study were that it was 




longer-term results needed follow up. After a 26-day program, FPG dropped from 178 to 
134, 77% discontinued oral hypoglycemic agents, 72% discontinued insulin, and one was 
placed on insulin. After a two and three year follow up FPG remained similar, but 40% 
restarted oral agents and 22% restarted insulin, with the calories from fat being the 
difference in adding back the medication (Barnard, Massey, Cherny, O’Brien, & Pritikin, 
1983). 
Just as Pritikin sought to treat his own CVD through diet, so did John McDougall, 
MD. Through his diet, he successfully reversed the effects of a massive stroke he 
experienced, which had left him paralyzed on the left side for 2 weeks (McDougall, 
2001). Between 2002 and 2011, 1,615 patients attended McDougall’s residential 
program, and after seven days in the program there was a reduction in CVD risk from 
7.5% to 5.5% (McDougall et al., 2014). Participants also showed significant health 
improvements in FPG, blood pressure, and lipid levels; 19%, 14% and 20% of 
participants reduced their SBP, DBP, and TC to normal, respectively. McDougall also 
published the first study, though small, on improving prognosis for breast cancer through 
a plant-based diet, which reduced cholesterol by 16%, prolactin by 38%, estrogen by 
37%, and estradiol by 45% (McDougall, 1984). 
Neal Bernard, a psychiatrist and founder of Physicians Committee for 
Responsible Medicine, has written approximately 17 books to date and routinely authors 
research articles linking health and nutrition (Barnard et al., 2014a; Barnard, Levin, & 
Trapp, 2014b; Bunner, Agarwal, Gonzales, Valente, & Barnard, 2014). When comparing 




al., 2009a) and 22-weeks (Turner-McGrievy et al., 2008), Barnard and his colleagues 
found that both diets were well accepted and adhered to, but the vegan diet led to a 
greater improvement in macronutrients intake, glycohemoglobin A1c (HgbA1c) and 
plasma lipids, while reducing the need for more medications (Barnard et al., 2009a).  
A 22-week worksite study with 109 employees with either diabetes or who were 
overweight found that that a vegan diet improved all health-protective nutrients and 
reduced TC and saturated and total fat, though LDL and TC differences were not 
statistically significant (Levin et al., 2010). Those on the vegan diet lost significantly 
more weight and reduced their BMI (Levin et al., 2010), and those in the intervention 
group experienced greater improvements in mental health, diet satisfaction, and physical 
health (Katcher, Ferdowsian, Hoover, Cohen, & Barnard, 2010). 
Lifestyle Medicine 
Lifestyle medicine is an evidence-based, clinical discipline focusing on the 
prevention, management, and treatment of disease through lifestyle changes such as diet, 
exercise, stress management, tobacco discontinuance, rest, alcohol reduction, and a 
variety of other nonmedical modalities (American College of Lifestyle Medicine, n.d.; 
American College of Preventive Medicine, n.d.). A healthy lifestyle is the first line of 
defense for many chronic diseases (Fraser, 2009), and while a call for uniformity in this 
practice has been attempted to help physicians feel more confident (Lianov & Johnson, 
2010), many believe they are still ill equipped to counsel on such topics (Dacey, 




be the foundation of our healthcare system” but is not covered by insurance, so is not 
included in most physician practices (Hyman, Ornish, & Roizen, 2009, p. 12).  
The American College of Lifestyle Medicine (2012) described CHIP (Rankin et 
al., 2012) as “yielding some of the most impressive recorded clinical changes ever in the 
literature. The results were achieved by volunteers, making this a most cost effective 
model for combating chronic disease.” Several other historical studies and pioneers 
highlight the effectiveness of lifestyle medicine. 
Lifestyle Programs 
Since the mid-1950s, longitudinal studies have begun to reveal associations 
between incidence, prevalence, predisposing factors, and prognosis between lifestyle and 
diet in type 2 diabetes; these long-term studies include the following: 
• the Framingham Study (Castelli et al., 1986)  
• the Nurses’ Health Study I and II (Belanger, Hennekens, Rosner, &, 
Speizer, 1978; Pan et al., 2011) 
• Health Professional Follow-Up Study (Pan et al., 2011)  
• the Adventist Health Study 1 and 2 (Rizzo, Sabate, Jaceldo-Siegl, & 
Fraser, 2011; Tonstad et al., 2009; Tonstad et al., 2013)  
• Adventist Mortality Study (Vang, Singh, Lee, Haddad, & Brinegar, 2008)  
In addition, live-in, residential lifestyle programs provide a controlled setting 
where participants learn to optimize their diet (McDougall et al., 2014, Slavicek et al., 




home and work to attend the program, only to return home to what is often minimal 
psychosocial support.  
An alternative to live-in, residential lifestyle programs are those that teach 
lifestyle principles in a classroom setting, instructing patients how to manipulate diet and 
lifestyle factors to reduce the risk or the prevalence of chronic diseases like diabetes or 
methods of controlling or reversing them. Examples of research using vegan, plant-based 
interventional programs include the following: 
• workplace research (Levin et al., 2010)  
• randomized, controlled studies (Barnard et al., 2009a)  
• the Diabetes Prevention Program’s clinical trials comparing diet to 
pharmaceuticals (Knowler et al., 2002) 
• private physician offices (Crowe, Ellis, Esselstyn, & Medendorp, 1995; 
Esselstyn, 1999) 
Many studies have shown the benefit of lifestyle approaches to be cost-effective 
and offer good value for the money (Bertram, Lim, & Barendregt, 2010; Eriksson et al., 
2010; Jacobs-van der Bruggen et al., 2009). 
Clinical Health Programs 
In addition to the residential lifestyle centers, current private practice practitioners 
such as surgeon, Caldwell Esselstyn, and Dean Ornish, also got involved in health reform 
teaching a plant-based diet without the use of animals. Results from research on 22 of 
Esselstyn’s patients with severe CAD revealed that after 10 years, CVD had been arrested 




based, low-fat diet (Crowe et al., 1995). Of the other 11 patients, six dropped out but 
remained on the diet without further cardiac events, the remaining five dropouts who 
returned to their original diet suffered a total of 10 cardiac events. Another study 
(Esselstyn & Golubic, 2014b) presented three case histories of patients with advanced 
heart disease progression who had been treated with the normal standard of care of 
multiple surgeries and medications, yielding unsatisfactory results. After switching to a 
whole-food, plant-based diet and removing animal products, each markedly and promptly 
improved. Another group of 177 patients reported similar results (Esselstyn, Gendy, 
Doyle, Golubic, & Roizen, 2014).    
Ornish published over 40 research articles on his plant-based comprehensive 
lifestyle program (Ornish, n.d.). He published the first randomized clinical trial to 
evaluate the progression of atherosclerosis without drugs, instead prescribing a plant-
based diet and lifestyle (Ornish et al., 1983; Ornish et al., 1990; Ornish et al., 1998). 
Compared to the control group, after 24 days, for the group that adhered to the diet, the 
frequency of angina episodes intervention was reduced by 91% and cholesterol by 21% 
(Ornish et al., 1983). Sixty-one percent of participants reported no chest pain after 3 years 
of continuing to be on the program at an average cost difference between $18,119 for the 
intervention group and $47,647 for the control group (Ornish & Multicenter Lifestyle 
Demonstration Project Research Group, 1998).  
In a study of 24 sites with 2,974 men and women, the Ornish program evaluated 
participants at baseline, after 24 weeks, and 12 months to evaluate longer-term results 




after one year, significant improvements in both subjective and CVD risk factors were 
seen in glycohemoglobin A1c (HgbA1c), BMI, LDL, TC, SBP, DBP, and TG; HDL 
remained unchanged. Due to the success of these comprehensive lifestyle programs, as of 
September 2010, Medicare reimbursed for both the outpatient Ornish program and the 
residential Pritikin program (Harvard Health Letter, 2010). 
Long-Term Studies in Lifestyle 
Epidemiological studies, with a focus on disease prevention, partnership, disease 
risk factor identification, disease surveillance, and disease cause and effect, are the 
cornerstones and guides of public health decisions and evidence-based practice 
(Blumenthal, & Yancey, 2004). Some of the first epidemiological studies were the 
infamous Tuskegee Syphilis Study (1932-1972; Roy, 1995) and the Framingham Heart 
Study (1948-present; Mahmood, Levy, Vasan, & Wang, 2014). In 1954, the Adventists 
began a progressive series of longitudinal, cohort studies: 
• Adventist Mortality Study (AMS; 1958-1966)  
• Adventist Health Study-1 (AHS-1; 1974-1988)  
• AHS-2 (2002-present), and their sub-studies 
• Adventist Health Air Pollution Study (1976-present)  
• Adventist Religion and Health Study (2006-present; Loma Linda 
University School of Public Health, 2015a)  
Other well-known non-Adventist, key epidemiological studies include the China-Cornell-
Oxford Project I and II (the China Study I [1983-1984] and II [1989-1990]), and the 




The Framingham Study followed 5,209 adults from Framingham, Massachusetts 
to understand cardiovascular disease. The study was inspired by health concerns after 
President Franklin Roosevelt (1882-1945) died from CVD (Mahmood et al., 2014). Out 
of this research came the Framingham risk scores, a 10-year prediction of cardiovascular 
risk development, which shifted the focus of CVD from treatment to prevention (Rodondi 
et al., 2012). With over 1,000 published medical articles, this study clearly shows an 
association between diet, lifestyle, and disease (Millen & Quatromoni, 2001; Millen et 
al., 2005; Millen et al., 2006; Posner et al., 1995; Wolongevicz et al., 2010).   
The China Study surveyed 6,500 people in 130 rural villages in China, examining 
the correlation between animal products and chronic disease such as diabetes, coronary 
artery disease (CAD), and certain cancers (Campbell, Parpia, & Chen, 1998). Campbell 
found that the greater the proportion of plant foods in the diet, the fewer chronic diseases, 
and that there was no point at which further reduction of animal products did not help. 
Rural China participants on average consumed a diet low in animal products and high in 
plant foods, which consisted of half the fat and three times the fiber than what Americans 
consume; 90% of their protein came from plants. Americans on average have a diet that 
is 30-45% fat; American men have a 16.7-fold increase in mortality rate over their 
Chinese counterparts, and American women have a 5.6-fold increase (Campbell & Chen, 
1999).       
The Nurses’ Health Studies (NHS) has yielded over 1,400 studies (National 
Health Sciences, n.d.) following 121,700 female nurses in NSH-1 and 116,671 female 




a clear correlation between meat consumption, other dietary factors and type 2 diabetes 
(de Munter, Hu, Spiegelman, Franz, & van Dam, 2007; Devore et al., 2009; Fung, 
Schulze, Manson, Willett, & Hu, 2004; Fung, McCullough, van Dam, & Hu, 2007; Jiang 
et al., 2002; Pan et al., 2011; Schulze et al., 2004; Schulze et al., 2005; Sun et al., 2010; 
Wedick et al., 2012).      
Adventist Health Movement History 
A worldwide, growing body of about 18 million members, the Seventh-day 
Adventist church is a conservative Protestant movement that believes the Christian 
experience is meant to pervade the whole life, emulating the gospel ministry and health 
ministry of Jesus (Seventh-day Adventist World Church, 2015a). Though they officially 
established themselves as a church in 1863, they have been meeting and growing since 
the 1840s (Seventh-day Adventist World Church [SDAWCH], 2015b). Since its 
inception, their movement has been based on health outreach, with now well over 75,000 
churches, 21 vegetarian-focused food industries, 175 hospitals and sanitariums, 136 
nursing homes and retirement centers, 269 clinics and dispensaries, 34 orphanages and 
children’s homes, and 10 airplane and medical launches, located in 216 of the 238 
countries around the world (SDAWC, 2015b).  
Founded by the Adventist church in 1956, their largest health and humanitarian 
outreach program is the Adventist Development and Relief Agency (ADRA), a leading 
nongovernmental organization (NGO) stationed throughout 125 countries (ADRA, n.d.). 
ADRA provides health promotion, humanitarian relief, food distribution, and disaster 




The focus of their worldwide work is to promote health, provide food and water, protect 
the vulnerable, support families, help establish livelihoods, and respond to emergencies. 
Their second largest faith-based health outreach program is the Adventist Health System 
(AHS), operating 8,100 licensed beds within 45 hospitals in 10 U.S. states, seeing more 
than 4.5 million patients per year (Adventist Health System, n.d.). The church also 
operates urgent care centers, hospice care, home health care, and skilled nursing facilities.    
In line with keeping their health vision, one of the Adventist’s 28 fundamental 
beliefs includes believing that the key to wellness lies in temperance and health reform, 
as well as keeping the body free from alcohol, tobacco, mind-altering substances, and 
other harmful chemicals (Ministerial Association, General Conference of Seventh-day 
Adventists, 2005). The Adventist health message also includes promoting clean, healthy 
lives through the intake of fresh air, pure water, moderate sunlight, daily exercise, one 
day weekly and nightly rest, trust in God, moderation of all things healthful, and a diet 
abstaining from meat but including legumes, nuts, grains, fruits, vegetables, and a source 
of B-12 (Seventh-day Adventist World Church, 2015c).  
The Adventist’s message of health started as early as 1848 when Ellen G. White 
(1827-1915) spoke out about the harmful effects of coffee, tea, and tobacco (White, 
1870). Progressively through her years, she presented new dietary and non-dietary health 
principles, as the denomination was able to accept more changes (Douglass, 1998, 
Emergence of a Health Message). Compilations of her decades-long messages of 
healthful living, reside under several titles but most notably, in Counsels on Diet and 




(1923), Ministry of Healing (1905), Temperance (1949), and Medical Ministry (1932), 
some of them compiled after her death, with some original titles and full books adopting 
more modern titles.   
White began to understand the relation of physical health to spirituality in 1863, 
and continued educating the church until the time of her death in 1915 (Douglass, 1998, 
Reviewing A Century of Health Reform Principles). Though many of these health 
principles are taught in modern days as a matter of fact and integrally related, in her day 
her views collectively were extreme (Douglass, 1998). The CHIP intervention and 
White’s principles share a similar healthful foundation. With only a third grade 
education, who claimed her message came from God, White’s health message (White, 
1938) included the following: 
• Obeying the natural laws of health will prevent many illnesses 
• Turning towards a healthy diet will help reverse diseases; improper eating is 
a cause of disease 
• Tobacco, coffee, tea, alcohol, and wine are slow poisons 
• Freely eat of fresh fruits and vegetables 
• Eat nuts in moderation. Some nuts are more healthful than others such as 
almonds are more healthful than peanuts. 
• Drinking plenty of pure fresh water will help maintain health and cure many 
illnesses 
• The flesh of swine is never to be eaten 




• Overworking breaks down the body 
• Overeating is intemperate 
• Temperance and moderation in all things healthful 
• Many people die prematurely solely from eating animal flesh foods and 
should not be eaten 
• Caring for the body is a spiritual commitment to God 
• Fasting provides curative powers 
• A time will soon come when eating dairy, cream, eggs, and butter will be 
unhealthful due to the increase disease of animals 
• Cleanliness of the home and body is important 
• Do not drink beverages including water with meals 
• Eat more raw foods and fewer cooked foods 
• Eating between meals is injurious to the stomach and digestive system 
• Eating two meals per day is better than three but if a third meal is taken in the 
day, it should be easily digestible and light, and should be taken several 
hours before bedtime. Adequate time between meals are necessary for proper 
digestion. 
• Rich cakes, pies, and puddings are injurious, as is the combination of sugar 
and milk 
• Those who are used to a meat-based diet will not at first relish a more simple 




•  Pickles, vinegar, spices, baking soda, baking powder, lard, cheese, grease, 
and too much salt are harmful 
Adventist-Related Research 
Adventists have been involved in health education since its inception in the 
1840s, educating both its members and the public (Robinson, 1965; Schwarz & 
Greenleaf, 2000). In 1954, Adventists entered the field of epidemiological research, and 
since then have published hundreds of peer-reviewed research articles (Hardinge & Stare, 
1954a; Hardinge & Stare, 1954b). Adventists have participated in five large, longitudinal 
studies all based out of Loma Linda, California: AMS (1958-1966), AHS-1 (1974-1988), 
Adventist Health Air Pollution Study (1976-present), AHS-2 (2002-present), and 
Adventist Religion and Health Study (2006-present), all focusing on the different aspects 
of relationship between diet, lifestyle, and disease (Lee et al., 2009; Loma Linda 
University School of Public Health, 2015b). Adventists have proven that they are quite 
willing to participate in health research studies.  
Adventists are an ideal group to study since by proscription for over 160 years, 
nearly all abstain from smoking (98.9%) and alcohol (95.4%), thereby reducing the 
confounding effects of these nondietetic factors (Butler et al., 2008). Adventists also 
abstain from biblically unclean meats such as fish without fins and scales, pork, and 
shellfish (Leviticus 11) and are encouraged to abstain from caffeinated beverages, tea, 
rich desserts, highly refined foods, and spices. Moreover, Adventists advocate exercise 
and a vegetarian diet high in fruits, vegetables, nuts, and grains—though a vegetarian diet 




group; the percentages may slightly vary from study to study, but generally the earlier 
studies reported Adventists were 4.2% total vegetarian or vegan, 31.6% lacto-ovo 
vegetarian, 11.4% pesco-vegetarian, 6.1% semi-vegetarian (having meat fewer than one 
time per week), and 46.8% not vegetarian (Butler et al., 2008). Partly as a result of diet 
and exercise, the earlier the age of baptism into the church, the lower the relative rate 
(RR) of death (Snowdon et al., 1982); for those baptized as children as compared to 
adults, the RR of ischemic heart disease death was 0.71, with reduced mortality rates for 
men but not women (Heuch et al., 2005).   
The AMS was the first major Adventist research study raising awareness to the 
link between diet and health, enrolling 22,940 Californians (Phillips, Lemon, Beeson, & 
Kuzma, 1978) with a 5- and 25-year follow up. Compared to the American Cancer 
Society (ACS), a group being researched at the same time as the AMS with similar 
education and incomes, Phillips et al. (1980) reported a lower mortality ratio in 
Adventists for all-cause cancers (males 0.60, females 0.76), all-cause deaths (males 0.66, 
females 0.88), coronary heart disease (males 0.66, females 0.98), and most cancers. 
However, despite the improved outcomes for diabetes, most cancers (breast, ovaries, 
colon, ovaries, rectum, and prostate), and vascular diseases, male Adventists had a higher 
ratio in stomach cancer (1.41) and women had an equal ratio in lymphoma and leukemia 
(1.00), as well as higher nonspecific circulatory conditions (1.01) than the ACS group.  
Comparing cancer risk of California Adventists with that of the general California 
population, many results were even better in outcomes for diabetes, vascular disease, and 




AMS brought up further questions regarding what specifically was it about the Adventist 
lifestyle that allowed them to live longer, which led into AHS-1 (Beeson, Mills, Phillips, 
Andress, & Fraser, 1989).   
AHS-1 was designed to discover which aspects of the Adventist lifestyle provided 
the disease protection found in the AMS (Beeson et al., 1989). Baseline data for the 
AHS-1 included 34,198 non-Hispanic Adventist California Caucasians, where 55.2% 
were ovo-lactovegetarian or vegan, 6% ate meat daily [Snowdon, 1988], and 50% were 
converts not born into the church;  researchers were able to follow up with 98.8% of the 
participants over 12 years (Beeson et al., 1989). A meta-analysis of five prospective 
studies, which included the AHS-1 and AMS, revealed that vegetarians had lower rates of 
death from heart disease (0.76 average) and mortality from any cause (0.95). Further, the 
vegetarians had lower cholesterol and BMI, less tobacco and alcohol use, and exercised 
more than nonvegetarians (Key et al., 1998). Eating nuts at least four times per week also 
reduced the risk of CHD by 37% (Kelly & Sabate, 2006). Overall, the survival advantage 
of California Adventists comparing vegetarians to nonvegetarians was 3.6 years of 
additional life in one study  (Singh, Sabate, & Fraser, 2003) and 7.28 years longer in men 
and 4.42 years for women in another study (Fraser & Shavlik, 2001). Longevity in 
Adventists has been known since 1969, when Lemon and Kuzma (1969) reported a 6.2-
year greater life expectancy in California Adventist men and 3.7 years for California 
Adventist women than the life expectancy of the general U. S. population. 
In 1977, researchers expanded the AHS-1 and began investigating the long-term 




diagnosed cancers, as well as the symptoms of emphysema, bronchitis, and asthma. The 
majority of Adventists do not smoke (98.2%), which reduces distortion when doing this 
kind of study (Beeson et al., 1989).   
The AHS-2 recruited over 96,000 Adventists from the United States and Canada, 
making it the largest prospective study of its kind (Butler et al., 2008), and includes the 
largest study on African Americans (Herring, Butler, Hall, Montgomery, & Fraser, 2010). 
They sought to answer a number of questions: Is heredity or lifestyle more important? 
Does faith influence health outcomes? Which foods prevent diseases such as 
Alzheimer’s, cancer, diabetes, arthritis, and heart disease? Which foods improve quality 
of life? In addition, why do African Americans have disproportionate numbers of heart 
disease and cancers? In the AHS-1 group (Butler et al., 2008), 8% are vegan compared to 
2% of the general population (Gallup, 2012), 28% are lacto-ovovegetarian compared to 
5% of the general population (Gallup, 2012), 16% are either pescovegetarian or 
semivegetarian, and 48% are nonvegetarian. 
Compared to nonvegetarians, the AHS-2, AHS-1, and AMS combined found 
vegans had 5 points lower BMI, 75% less risk of hypertension, between 47% and 78% 
lower risk of diabetes, 14% less risk of all-cancer, but had a 73% increase risk of urinary 
tract cancer, 42% lower risk in CVD mortality, and 55% lower risk for ischemic heart 
disease (IHD; Le & Sabate, 2014). Le & Sabate (2014) also found that the dietary habits 
of Adventists contain more fiber than the average intake, and those that do eat meat, 




does not account for all. In addition to diet, socialization and religion have also been 
predictors of longevity—hence, the Adventist Religion and Health Study.    
The Adventist Religion and Health Study is a subset of the AHS-2 group 
consisting of 11,000 United States and Canadian Adventists, which set out to determine 
which aspects of religion effected health outcomes (Lee et al., 2009). So far, this study 
has shown that those who have higher intake of fresh fruits, vegetables, olive oil, beans, 
and nuts have improved moods and food choices, while desserts, soda, fast food, sweets, 
and red meat were associated with a negative mood and additional negative food choices 
(Ford, Jaceldo-Siegl, Lee, Youngbert, & Tonstad, 2013). Other preliminary results show 
that those who experience poverty are more religious, but abused individuals are less 
religious. Further, religious engagement may improve health outcomes for adults when 
they experienced abuse early in life (Morton, Lee, Haviland, & Fraser, 2012).   
Some of the limitations of the Adventist Health Studies are as follows:  
1. Little dietary data on fruit and vegetable intake were collected in AMS, and 
information was not gathered on meat substitutes that many Adventists use, such 
as beans, nuts, and prepackaged vegetarian protein (Snowdon, 1988).  
2. Information on social or church activities were not collected, despite these having 
been shown to reduce mortality and could have created confounding on a 
vegetarian diet and disease outcomes (Snowdon, 1988).  
3. Four to seven percent of data items on the questionnaire were not answered, 




4. The questionnaire took on average between 1.25-3.5 hours to complete, and had a 
low rate of males (34.9%) and Hispanics (0%). The questionnaire was not offered 
in Spanish (Butler et al., 2008).  
5. Since only Adventists are represented, the findings are less generalizable to other 
non-Adventist vegetarians.  
6. The baseline for the vegetarian and vegan diet were the Adventist meat-eaters, 
who in general eat less meat than the general population (Le & Sabate, 2014). 
This reporting may result in smaller observed effects.  
The strengths of the Adventist Health Studies include the following:  
1. Many studies have greater than 90% participant follow up; other researchers are 
glad to get 50% on these kinds of studies.  
2. Adventists have low alcohol and tobacco use, which reduces confounding and 
increases statistical power. 
3. There is church support at all levels: members are willing to participate in 
research and administration encourages members to participate. 
4. AHS-2 has an in-depth food questionnaire. 
5. AHS-2 includes broad geographical locations. 
6. AHS-2 includes a large number of Blacks.  
7. AHS-2 includes a comprehensive calibration study measuring error and validity 




8. The focus of these studies represent vegetarian Adventists, and the study uses 
consistent operational definitions of differing dietary patterns (Le & Sabate, 
2014).  
Complete Health Improvement Program (CHIP) History 
In addition to the denominational-wide prospective Adventist Health Studies, 
many members have also started independent health ministries, such as residential and 
community health programs; CHIP is one such program. Hans Diehl founded the 
Complete Health Improvement Program in 1986 after working with Nathan Pritikin, the 
founder of the Pritikin Longevity Center, a residential, live-in lifestyle center (Morton et 
al., 2014a). As participants progressed through this lifestyle program, Diehl found 
significant improvements of their chronic diseases within only a few weeks. The Pritikin 
Program guidelines consisted of a very low fat, low sodium, high fiber, plant-based diet, 
except for one 3.5 ounce serving of fish or chicken once per week, 45-60 minutes of daily 
exercise, and no alcohol, tobacco, or caffeine (Roberts, Nosratola, & Barnard, 2002). The 
diet allowed for 10% fat, 25 mg of cholesterol, 10%-15% mainly plant protein, and 75%-
80% complex carbohydrates (Pritikin, 1984). Sixty-seven subjects (52 men and 15 
women; mean age, 60±10 years) on  the Pritikin three-week residential program showed a 
31% reduction of metabolic syndrome by implementing the very low fat, high fiber, low 
sodium diet (Sullivan & Klein, 2006). Eleven men (21%) showed a 41.3% reduction in 
LDL, a 46.2% reduction in fasting insulin, a 13.6% drop in SBP, a 9.8% reduction in 
DBP, a 41.3% reduction in TG, and a 14.8% drop in HDL (Roberts, Nosratola, & 




 Seeing the limitations to this artificial but powerfully-principled residential health 
setting, Diehl set out to create his own program teaching similar health principles, except 
offering it in a 30-day community setting. His program cost less by negating the necessity 
of having to leave work or travel distances, it provided community support, and allowed 
participants to grow and adapt in their own home environment as they learned through 
the program (Morton et al., 2014a). Diehl presented his first 4-week, 16-session CHIP 
program in 1988 in Creston, British Columbia, Canada to an audience of 400. For the 
next several years, he traveled in and out of the United States teaching CHIP.  
The primary goal of the program was to reduce the symptoms associated with 
heart disease and diabetes, such as high lipids, blood pressure, and blood sugars through a 
whole-food, plant-based, vegan diet (Diehl, 1998). The secondary goal was to reduce 
weight, reduce the need for pharmaceuticals, eliminate tobacco, improve stress, and 
increase exercise (Diehl, 1998). The CHIP diet, called the Optimal Diet, and lifestyle 
consists of 30 minutes of daily exercise (Morton et al., 2014b), 15% fat, 10%-15% plant 
protein, 65%-70% complex carbohydrates, fewer than 50 mg cholesterol, fewer than 10 
teaspoons sugar, low salt, at least 40 grams fiber, and 8-10 glasses of water (Englert, 
Diehl, Greenlaw, Willich, & Aldana, 2007). Participants were encouraged to stop 
smoking and attend monthly alumni meetings. CHIP was driven by the theory of planned 
behavior (TBH; Ajzen, 1985), which included a strong educational component, targeting 
attitudes, social norms, and perceived volitional control.  
In 1997, sponsored by the Lifestyle Medicine Institute, the International Nutrition 




Interest, Diehl videoed the program for a live audience in Kalamazoo, Michigan and 
presented the first research of that group in 1998 (Diehl, 1998). This program was 
packaged into a curriculum for both professionally educated health professionals and 
nonhealth trained volunteers who attended a 2-day CHIP training session (Rankin et al., 
2012). The Kalamazoo program graduated 288 self-selected, paying participants. 
Being a health professional was not a criterion for volunteers since the directors 
had only a facilitator’s role, not an educator’s role. Health education was presented by 
Diehl via video, and the volunteers then directed group discussions, gave cooking 
demonstrations, and provided grocery store tours. The volunteer channel has been largely 
adopted by the Seventh-day Adventist church (Morton et al., 2014a). In 2000, Roger 
Greenlaw initiated the professional CHIP channel with the Rockford cohort program, 
enrolling 1,517 paying, self-selected participants between 2000 and 2002 (Englert et al., 
2007) with a goal of enrolling 5,000 participants over seven years, giving the program 
every six months (Englert et al., 2004). CHIP continues to be an intensive educational 
program given in 40 hours over four to five weeks, four evenings per week plus two 
Sundays. 
CHIP-Related Research 
CHIP has now educated over 70,000 participants worldwide by professionals and 
volunteers and has been written up in more than 25 publications (Morton et al., 2014a). 
This present study made use of 22 peer-reviewed research studies on the CHIP program. 




intervention, seven examined volunteers, and one summarized the history of CHIP for 
both volunteers and professionals, and all are discussed next. 
First-recorded CHIP: Kalamazoo, Michigan. In 1997, Diehl delivered and 
video recorded CHIP before 400 people in Kalamazoo, Michigan and published the first 
CHIP results in the American Journal of Cardiology (Diehl, 1998). Two hundred and 
eighty-eight graduated of the 304 enrollees (Diehl, 1988). Consistent with later CHIP 
research, those with the greatest needs improved the most (Diehl, 1998; Englert et al., 
2004; Morton et al., 2014a; Rankin et al., 2012). Men who had cholesterol levels above 
279 mg/dL reduced their cholesterol by 33%, 34% saw a reduction in LDLs with levels 
greater than 189 mg/dL, 39% saw a reduction of TG if between 400 and 599 mg/dL, but a 
lowering of HDL if their total-to-HDL cholesterol ratios were above 6.0 mg/dL (Diehl, 
1998). Morbidly obese men (150% ideal body weight or higher) lost 13.7 pounds, the 
most of any weight category after the four-week program. FPG also improved over the 
program length. Thirty percent of those with diabetes cut their insulin by as much as 
30%, which increased confounding, due to the reduction of diabetes and other 
medications for hypertension and hyperlipidemia. The above results may actually be 
more profound since most participants reduced or eliminated medications. 
Though men improved more than women overall, women improved as well 
(Diehl, 1998). Women lost on average 5.2 pounds, glucose dropped by 6.7%, TC dropped 
by 21.6 %, and similar to men, dropped also in the good HDL cholesterol by 6.6 %, 
which has subsequently been written up in Kent et al. (2013b). 




professional Rockford CHIP cohort appeared in 2004 (Englert et al., 2004). Fifteen peer-
reviewed articles highlighted results from Rockford, all given by health professionals in 
either a community (Englert, Diehl, & Greenlaw, 2012) or workplace setting (Aldana, 
Greenlaw, Diehl, Englert, & Jackson, 2002). Another professionally delivered CHIP 
intervention program out of Vanderbilt University (Shurney et al., 2012) published an 
article tracking healthcare expenditures of employee participants for 26 weeks.  
The Rockford CHIP (Englert et al., 2004; Englert et al., 2007) found similar 
results in all biometrics as Kalamazoo, and additionally found reduced depression and 
improved sleep and stress through nutrient improvement (Merrill, Taylor, & Aldana, 
2008). However, serum C-reactive protein (CRP) did not significantly improve over 
baseline despite improvements in weight, BMI, saturated fat, and body fat percentage 
(Merrill et al., 2008). The researchers suggested that was possibly due to the small 
sample size in an otherwise generally healthy population. In addition, as with the 
Kalamazoo population, men in the Rockford population improved more over women, 
though both improved, and those with the highest risk factors had the greatest 
improvements, this included those with high blood sugar levels (Englert, Diehl, 
Greenlaw, & Aldana, 2012). Of the 237 participants who had diabetes, 154 were on 
diabetes medications, and 83 were unaware of their diabetes status. Forty-two percent of 
participants on insulin, and 44% on oral antidiabetics were advised by their doctor to 
reduce their dosage. Thirty-five percent reduced their glucose below 125 mg/dl and 10% 
reduced it to below 100 mg/dl in 30 days. 




through a professional channel, it has also been largely adopted by the Seventh-day 
Adventist church through a volunteer channel delivered by trained nonmedical people in 
their local community (Morton et al., 2014a). Volunteers attended a 2-day training 
workshop and learned about the video-presentations and their role as facilitators (Rankin 
et al., 2012). To date, five peer-reviewed articles (Kent et al., 2013b; Kent et al., 2014; 
Morton et al., 2014a; Morton et al., 2014b; Rankin et al., 2012) on the North American 
volunteer programs have resulted from a dissertation by Rankin (2013), and since then, 
groups from Australasia (New Zealand and Australia; Kent et al., 2013a; Morton et al., 
2013); and Appalachia, Ohio in the United States (Drozek et al., 2014) have also been 
reported on. Morton et al. (2014b) gives a comprehensive picture of the CHIP history, 
evaluation, outcomes, and comparisons of previous professional and volunteer programs 
and Morton et al., (2014b) reported specifically on Canadian outcomes. 
Of the seven volunteer-delivered research articles published in peer-reviewed 
journals, one focused on the HDL implications in the metabolic syndrome and the 
potential lack of its usefulness (Kent et al., 2013b); one focused on gender differences on 
chronic risk factors (Kent et al., 2014); one examined aggregated outcomes of Canadian’s 
pre- and postdisease risk factors—BMI, SBP, DBP, FPG, and blood lipid profile (Morton 
et al., 2014b); one looked at the pre- and postdisease risk factors of the North American 
CHIP cohort (Rankin et al., 2012); and one presented the CHIP history, evaluation, and 
outcomes summarizing the risk factors in both the volunteer and professional delivered 
programs (Morton et al., 2014a). The dissertation focused on reducing risk factors 




Similar to the North American disease risk factor results, rural Appalachia, Ohio 
(Drozek et al., 2014) and Australasia (Morton et al., 2013) were also assessed for risk 
factors immediately following the CHIP program. A subset of the Australasia cohort 
(Kent et al., 2013a) was assessed for long-term effectiveness. Comparable to the 
professionally-delivered, prerecorded CHIP intervention, the volunteer-delivered, 
prerecorded CHIP intervention garnered similar results: those with the highest chronic 
disease risk factors made the greatest improvements (Rankin et al., 2012), HDL dropped 
despite improved outcomes in other risk factors (Kent et al., 2013a), and men improved 
more than women, though both genders improved overall (Kent et al., 2014).  
Both the professionally-delivered (PD) and volunteer-facilitated (VF) programs 
assessed pre- and postbiometric changes in TC, HDL, LDL, TRI, BMI, SBP and DBP, 
and FPG (Morton et al., 2014a). In aggregated data, the mean age for the VF (n=7085) 
was 2.7 years older, at 56.8 years, than the professionally-delivered (PD; n=4678), both 
had more females than males, BMI was reduced by 3.5% (PD) and 3.3% (VF), SBP drop 
was equal at 5.0%, DBP dropped 5.2% (PD) and 5.1% (VF), TC dropped 11.3% (PD) 
and 11.4% (VF), HDL dropped 9.1% (PD) and 13.4% (VF), LDL dropped 12.5% (PD) 
and 8.6% (VF), TG dropped 7.3% (PD) and 8.1% (VF), and FPG dropped 5.5% (PD) and 
6.1% (VF). 
In comparison, considering the outcomes of the volunteer-delivered program, it 
may present itself as a cost-effective adjunct to professional health care (Shurney et al., 
2012). Shurney et al. (2012) reported significant savings in medical costs in CHIP 




the following year’s quarter. Medical costs were reduced by 45.5% and 40.3% in quarter 
one and two compared to an increase in medical costs of 5.4% and 21.2% in the same 
two quarters for non-CHIP participants with diabetes. Prescription costs also declined by 
14.7% and 13.8% in quarter one and two for CHIP participants, but rose by 11.5% and 
7.6% for non-CHIP participants. The average number of office visits was significantly 
reduced, as was the number of prescriptions filled. Other comprehensive lifestyle 
modification programs have seen similar results such as the Diabetes Prevention Program 
(DPP), which has shown prevention or delay in diabetes incidences for 10 years for 
lifestyle (34% reduction) versus metformin (18% reduction; Knowler et al., 2009), but 
without the pharmaceutical side effects (Hung et al., 2015; Kalantar-Zadeh & Rhee, 
2015).    
Several factors may explain the significant biometric risk reduction as observed in 
the CHIP intervention. Participants were self-selected and may have been more motivated 
and ready for change, as shown by a low attrition rate (3%), the necessity to pay for the 
program (Morton et al., 2014b), and a short 4-week intervention (Morton et al., 2014a). 
Limitations in the CHIP intervention included a lack of control group, and compliancy 
was not evaluated. A confounding factor was that many participants either discontinued 
or reduced their medication use, potentially diminishing the observed effectiveness in 
biometrics (Rankin et al., 2012). Despite the limitations, CHIP’s strength is the sample 
size, and the strong and focused educational element, which concentrates on 
comprehensive lifestyle choices of improving diet, exercise, and sleep, stress reduction, 




2014). CHIP addresses the root causes of diabetes, which is diet and lifestyle.   
Although most volunteer-facilitated CHIP programs are presented by Adventists, 
and a body of evidence exists comparing mean changes in the pre- and postprogram 
disease risk factors and between genders, a literature gap exists when it comes to 
understanding how having a specific faith belief  may affect biometric outcomes within 
the CHIP program for those with type 2 diabetes. It is also unknown if Adventists enter 
the CHIP program with a different rate of diabetes compared to non-Adventists. 
CHIP Video-Presentation 
The volunteer- and professionally-delivered CHIP program consisted of sixteen 2-
hour group sessions, which included a 1-hour recorded health lecture by the founder, 
Diehl, live demonstration cooking classes, a grocery store tour, group discussions, and 
exercise classes (Englert et al., 2004; Rankin et al., 2012). Video content instructions 
included the following: 
• plant-based nutrition  
• exercise 
• behavioral change  
• self-worth  
• accomplishments and limitations of modern medicine  
• smoking  
• cholesterol  
• dietary fiber  




• CVD  
• diabetes  
• atherosclerosis  
• hypertension  
• obesity 
• dyslipidemia (Englert et al., 2004; Rankin et al., 2012)  
Video-facilitated education has been used successfully in a variety of health 
education programs. Maltinsky, Hall, Grant, Simpson, and MacRury (2013) evaluated a 
work-based pilot video conferencing program targeting diabetes education for rural 
healthcare professionals with limited training options. Video conferencing promoted 
equal learning as in-person, but had less spontaneous interaction with the instructor. A 
different qualitative, motivational, video-based program (Essien et al., 2011) assessed the 
cost-effectiveness, stability, and feasibility in HIV prevention for women in Southwestern 
Nigeria (n=346) where resources were limited. The results indicated that both the 
interventional motivational video and the control didactic video equally increased HIV 
knowledge, but the motivational video significantly improved condom use and reduced 
the number of sexual partners and alcohol use before sex at the six-month follow up over 
the didactic video. The limitation in this study is that all behavioral outcomes were self-
reported, and subjects were from a convenience sample. However, there was random 
assignment, and retention rate was high.  
In another study, a tuberculosis (TB) video-education program shown to 




the United States (n=159) increased TB knowledge, with participants increasing test 
scores from 56% to 82% correct. Ninety-four percent of those using ESL stated the video 
instruction format was appropriate for learning, and self-efficacy increased from 77% to 
90% (Wieland et al., 2013). Overall, knowledge increased significantly in all learning 
sections by viewing video-recorded educational sessions. These studies and others 
highlight the effectiveness of using a prerecorded educational video as a learning medium 
(Canter, Rao, Patrick, Alpan, & Altman, 2015). 
Volunteer-Delivered Lifestyle Programs 
Volunteer-faciliated, community-based, lifestyle programs have the potential to 
impact larger numbers of people while reducing costs significantly (Baron et al., 2008; 
Knowler et al., 2009; Siabani, Driscoll, Davidson, & Leeder, 2014; Shurney et al., 2012). 
The purpose of this dissertation was to analyze the volunteer-facilitated aspect of the 
CHIP intervention, though medical professionals also present the intervention program 
and have been studied separately. The CHIP intervention has mainly been adopted by 
volunteers from the Seventh-day Adventist church wishing to affect positive change in 
their community (Morton et al., 2014a). Extant literature reveals the most common 
volunteer setting is related to a health-orientation setting, with the volunteer possessing a 
protestant or Catholic religious affiliation, and who engages in prayer with altruistic 
values (Moore, Warta, & Erichsen, 2014).  
In other research, health indicators for chronic heart failure (Siabani et al., 2014), 
CVD risk factors (Rankin et al., 2012), and an at-home exercise program (Castro, Pruitt, 




following educational programs presented by trained volunteers. More encouraging, 
some research shows that trained volunteers may be more effective than paid 
professionals (Castro et al., 2011), and equally as effective (Morton et al., 2014b). 
Whether the trained volunteer is a peer or an undergraduate college student and younger, 
participants significantly improve their health outcomes under their guidance (Dorgo, 
King, & Brickey, 2009). Research shows that both participants and volunteers benefit in 
perception, enjoyment, motivation, role modeling, and retention whether receiving or 
presenting the program (Dorgo et al., 2009). 
Summary and Conclusion 
Diabetes is having a substantial impact on society in health and life expectancy 
and in health care costs for individuals, employers, and state and federal budgets. A 
plethora of dated and contemporary evidence exists in the literature showing the 
effectiveness of a comprehensive lifestyle, plant-based, vegan program in the reduction 
of chronic diseases such as diabetes and CVD; the cure and reversal is in the cause. 
Adventists have been successfully sharing a progressive and unique health message with 
the world in a multitude of settings since the 1840s, which reverses and reduces the risk 
of disease. Studies also show that lifestyle approaches are more cost-effective than a 
pharmaceutical, Western type of approach while reducing medication usage. Research 
reveals that Adventists and non-Adventists who follow this counsel and adhere to a plant-
based diet have lower incidences of diabetes and CVD. Adventist programs such as CHIP 
focus on diet, exercise, and stress reduction and have the potential to impact large 




disease. Despite a lack of control group and selection bias, with its large sample size, the 
CHIP modification intervention has shown to be an effective 30-day, community-based, 
video-presented, plant-based, lifestyle program delivered by both volunteers and 
professionals. The CHIP research has been consistent showing that participants with the 
greatest needs improved the most, and men improved more than women did though all 
improved. However, despite the volunteer program being presented and adopted mainly 
by the Adventist church, there was a research gap when assessing program effectiveness 




Chapter 3: Research Method 
Introduction 
The purposes of this study were to determine the relationship between religiosity 
and preprogram diabetic rate, and to compare if having a particular religious belief 
(Adventist or non-Adventist) significantly affected biometric outcomes for those with 
type 2 diabetes pre- and post-CHIP. This quantitative, correlational, secondary data, 
research design study examined the rate difference between religiosity and self-identified 
preprogram diabetic state, and assessed how religiosity affected postbiometrics. The 
Walden University Institutional Review Board (IRB) approved this research with 
approval number 11-09-15-0065108. 
The following research questions guided this study: 
Research Question 1 (RQ1): After controlling the effects of age, gender, marital 
status, BMI, and parental death from diabetes before age 60, is there a statistically 
significant difference in self-identified type 2 diabetes prevalence rates between 
Adventist and non-Adventist CHIP participants preprogram between January 2006 and 
September 2012? 
H01: The self-identified diabetes prevalence rate between Adventist and non-
Adventist in pre-CHIP participants is not significantly different. 
H11: The self-identified diabetes prevalence rate between Adventist and non-
Adventist in pre-CHIP participants is significantly different. 




Research Question 2 (RQ2): After controlling for the effects of age, gender, 
marital status, and parental death from diabetes before age 60, is there a statistically 
significant difference in the change in biometric outcomes (TC, HDL, LDL, TG, FPG, 
SBP, DBP, and BMI) between Adventists and non-Adventists with self-identified 
diabetes pre- and post-CHIP between January 2006 and September 2012? 
H02: There is no statistically significant difference in biometric outcomes 
between Adventists and non-Adventists with self-identified type 2 diabetes pre- and post-
CHIP. 
H12: There is a statistically significant difference in biometric outcomes between 
Adventists and non-Adventists with self-identified type 2 diabetes pre- and post-CHIP. 
The quantitative test used to answer RQ2 was a MANOVA. 
Research Design and Rationale 
This study utilized a quantitative methodology with a correlational design using a 
secondary data set from CHIP. This quantitative approach was selected in order to 
understand statistically how lifestyle factors relate to disease outcomes and having a 
specific faith belief. Correlational research was conducted because this design looks at 
relationships among variables (Leedy and Omrod, 2010). There were no time or resource 
constraints in this study; the overall objective was to determine the relationships between 
the variables of religiosity, preprogram diabetic state, and biometric outcomes.  
In RQ1, the independent variables were religiosity and pre- and post-CHIP 
measurement testing periods. The dependent variable was self-identified diabetes, having 




status, BMI, and parental death from diabetes before age 60. In answering RQ1, an 
experimental design using logistic regression was employed to quantify the difference in 
diabetes rate between Adventists and non-Adventists. 
The independent variables for RQ2 were religiosity and testing period. The 
dependent variables were the biomarker outcomes attained through blood sample testing 
for TC, HDL, LDL, TG, and FPG and the clinical parameters of SBP, DBP, height and 
weight measurements for BMI, and the covariates were age, gender, marital status, and 
parental death of diabetes before age 60. In answering RQ2, MANOVA, a correlational 
research design was used to quantify the biometric changes from pre- to post-CHIP in 
Adventists and non-Adventists with type 2 diabetes. 
Methodology 
Population 
The total population of 7,172 included community members from 241 programs 
located at 163 venues throughout Canada and United States between January 2006 and 
September 2012. The population consisted of those who self-identified themselves as 
Adventist or non-Adventist, self-identified themselves on the health-screening 
questionnaire as having been told by a doctor they had diabetes, and graduated from the 
CHIP program. The CHIP participants underwent a total of 32 hours of instruction over a 
30-day period that included the following: 
● a one-hour video-instruction health lecture by Hans Diehl 
● cooking classes 




● group discussions 
● exercise instruction (Rankin et al., 2012) 
● instruction on intelligent self-care through more self-awareness of what their 
body needed and how it felt.  
The one-hour video-instruction included education on the following:  
● a plant-based diet 
● exercise 
● behavioral change 
● self-worth 




● lifestyle and health 
● the epidemiology and risk factors of CVD, diabetes, atherosclerosis, 
hypertension, obesity, and dyslipidemia (Rankin et al., 2012).  
Participants were also encouraged to move towards a whole-food, plant-based, 
vegan diet emphasizing fresh fruits and vegetables, whole grains, legumes, and nuts 
without emphasis on caloric restriction. Specific dietary and lifestyle recommendations 
included the following:  
● <15% of calories from fat 




● <5,000 mg salt (2,000 mg sodium) 
● <50 mg cholesterol 
● consuming 2-2.5 liters or eight 10-ounce glasses of water daily 
● 30 minutes of daily aerobic exercise 
● stress reduction strategies 
● encouragement to join the CHIP monthly alumni support group (Rankin et al., 
 2012). 
Participants were also encouraged to maintain contact with their physician 
throughout the program, since experience has shown many participants need to have their 
medications reduced due to these lifestyle changes. Prior to CHIP, all filled out a 
preprogram baseline health questionnaire, and again post-CHIP. Included were questions 
about demographics, medication use, medical and family history, use of tobacco, alcohol, 
and caffeine, religiosity, and behaviors of activity, rest, and diet. Trained phlebotomists 
also drew blood for TC, HDL, LDL, TG, and FPG. Each participant was weighed and 
measured for height to calculate BMI and had their blood pressure taken.   
There were no restrictions on participant demographics of age, gender, marital 
status, BMI, or parental death of diabetes prior to age 60, and were controlled for. To be 
included, participants had to have graduated from a CHIP program, defined as having 
attended at least 13 of 16 sessions, completed a self-reported medical and lifestyle 




Sampling and Sampling Procedure 
The required sample size for this study was calculated to determine the number of 
samples necessary for a statistically significant result. The sample size was calculated 
considering three factors:  (a) effect size, (b) level of significance, and (c) power of the 
study. Cohen’s (1988) effect size accounts for the strength of the relationship between 
variables. The level of significance or alpha level was used to assess the null hypothesis, 
providing it was true, for the probability of its rejection. The power of the study was 
determined by the probability of being able to reject a false null hypothesis. A Cohen 
medium effect size of 0.25, a power of 0.80, and a level of significance of 0.05 were used 
in this study. A power of 0.80 is in alignment with Gravetter and Wallnau’s (2013) 
statement, which is normal for quantitative research. Use of the medium effect size was 
intended to prevent excessiveness in terms of either leniency or strictness, 
simultaneously. A significance level of 0.05 was used because this is typical for 
quantitative studies. 
A G*Power sample calculator was used to compute the required sample size for 
this study, as suggested by Faul, Erdfelder, Lang, and Buchner (2009). A two-tailed or 
nondirectional hypothesis test was conducted, employing the statistical test of repeated 
measures MANOVA with two groups (Adventists with diabetes and non-Adventists with 
diabetes) and two numbers of measurements (pre- and postprogram). A medium effect 
size in the sample size computation involved in the repeated measures MANOVA, and 
the value of the medium effect size for an ANCOVA test is 0.25. A medium effect size 




sample size. The important factors under consideration were to be able to achieve an 80% 
power in the statistical analysis, which meets the minimum size for a quantitative 
analysis, and to have a level of significance of 0.05. 
The minimum sample size for this study computed by the G*Power sample size 
calculator was 66 (see Appendix A). A minimum of 66 individuals had to be included so 
that the power of the statistical analysis reached 80%, which would allow the null 
hypothesis to be rejected. To account for the minimum 66-sample requirement, the 
participants were divided among the two sample groups of Adventists with diabetes 
(n=210) and non-Adventists with diabetes (n=836), for a total of 1,046 data sets. 
Data were obtained from the CHIP database, a secondary source. A purposeful 
sampling strategy was chosen because study participants had to match inclusion criteria 
in order to be eligible for participation in the study. The inclusion criteria were as 
follows:  self-identified as Adventist or non-Adventist; self-identified as having diabetes; 
having graduated from CHIP, and filled out the proper questionnaires. All ages in the 
original samples were included. 
Procedures for Recruitments, Participation, and Data Collection: Using Archival 
Data 
The data required for RQ1 included the dependent variable of diabetes state; the 
independent variables of self-reported religiosity affiliation and testing period; and the 
covariates of age, gender, marital status, BMI, and parental death from diabetes before 
age 60. The data required for RQ2 included the dependent variables of TC, HDL, LDL, 




testing period as the independent variables; and the covariates of age, gender, marital 
status, and parental death of diabetes prior to age 60. BMI was a covariate for RQ1 and 
an outcome variable for RQ2. The variable information was obtained through secondary 
data collection from the CHIP database between January 2006 and September 2012. 
Secondary data were obtained from the CHIP database and its analysis used as an 
investigative tool for answering new questions (Andrews, Higgins, Andrews, & Lalor, 
2012).  
To achieve access, a written request for permission to utilize CHIP information 
was submitted to the Lifestyle Medicine Institute with a description of how it was to be 
used. This email consisted of the permission letter, an explanation of the purpose of the 
study, and how the data were to be used in the study. In return, the CHIP organization 
will receive an overall summary report at the study’s conclusion. 
The CHIP database resides in Wahroonga, Australia. In the course of my contacts 
with CHIP researchers, they had given permission and encouragement to analyze the 
CHIP data for this study. See data use agreement in appendix C. The data from the CHIP 
database represented 7,172 unidentifiable, self-selected subjects from 241 volunteer-
delivered CHIP programs conducted at 163 locations throughout Canada and the United 
States between January 2006 and September 2012. The CHIP database consisted of age, 
gender, marital status, TC, HDL, LDL, TG, SBP, DBP, FPG, BMI, and self-identified 
diseases and religious affiliation. 
The deidentified data set was provided in an Excel spreadsheet format that needed 




anonymity codes were assigned in place of participants’ names. Data preparation was 
conducted in an Excel sheet to prepare for data analysis. The columns displayed the study 
variables as an enumerated list, while the rows listed the response data of the different 
samples. 
Instrumentation and Operationalization of Constructs 
The data gathered through the CHIP database were representative of the total 
sample of Adventists and non-Adventists who had diabetes since it included all 
participants who participated under the volunteer-branch of CHIP between January 2006 
and September 2012. The data gathered from the data source were analyzed using SPSS 
v23.0 software in preparation for the data analysis. There were no issues with the validity 
and reliability of the data, as they were derived from both secondary and preexisting 
sources. No testing or survey assessments were used with the targeted samples. It was 
expected that the data of the samples in the CHIP database were complete. The coding 





Operationalization and Coding of Study Variables 
Variable Name Variable Type Operationalization Coding/Values 
Self-identified 
preprogram 
diabetic state  
Dependent 
variable 
Categorical 1 = Previous history 










Continuous Actual number of LDL  
Triglycerides  Dependent 
variable 
Continuous Actual number of TG 
Total cholesterol  Dependent 
variable 










Continuous Actual number of systolic blood 
pressure or the top number of 





Continuous Actual number of diastolic blood 
pressure or the bottom number of 
the blood pressure chart 
Body mass index 




Continuous Actual number of body mass index 
computed by dividing the weight 
in kilograms (kg) with the height 









Categorical 1/True = Seventh-day Adventist  
2/False = non-Adventist  
   
Testing period Independent 
variable 
Categorical 0 = Pretest 
1 = Posttest  
   
Age Covariates Continuous Actual number of age at baseline 
date of birth 
Gender Covariates Categorical 1 = Male 
  2 = Female 
Marital status Covariate Categorical 1 = Single, divorced, or widowed 
2 = Married 
Parental death 
from type 2 
diabetes before 
age 60 
Covariate Categorical 1 = With family history 





Data Analysis Plan 
Data were analyzed using SPSS version 23.0. Normality testing was conducted on 
the data of the study variables of the population to ensure that the assumptions required 
for a parametric statistical test were fulfilled. The analysis was conducted by examining 
the skewness and kurtosis statistics, as well as the normality plots in the histograms. 
Normal distribution of data were a required assumption of parametric statistical analysis 
such as the MANOVA analysis. In addition, a line graph was created from the data of 
each study variable to account for the possible presence of anomalous figures or 
noticeable outliers within the data prior to conducting the statistical analysis. These 
outliers were removed from the data set. 
Descriptive and inferential statistics were used to analyze the data gathered and 
presented in Chapter 4. Descriptive statistics describe the demographics and other 
information of the samples and study variables obtained from the CHIP database. 
Frequencies and percentages describe categorical data, such as the dependent variable of 
biometric outcomes, the independent variables of religiosity and testing period, and the 
covariates of gender, marital status, and parental death from diabetes prior to age 60. 
Central tendency measures of mean and standard deviation summarizes the continuous 
variability of the dependent variables, which included the biometric measurements of TC, 
HDL, LDL, TG, and FPG; height and weight measured for BMI, SBP, and DBP; and the 
covariate of age. Percentages of those who met the criteria of each biometric variable pre- 
and post-CHIP were added to provide information on the percentage of those who met or 




The research questions, hypotheses, and discussion on specific analysis follows. 
Research Question 1 (RQ1): After controlling the effects of age, gender, marital 
status, BMI, and parental death from diabetes before age 60, is there a statistically 
significant difference in self-identified type 2 diabetes prevalence rates between 
Adventist and non-Adventist CHIP participants preprogram between January 2006 and 
September 2012? 
H01: The self-identified diabetes prevalence rate between Adventist and non-
Adventist in pre-CHIP participants is not significantly different.   
H11: The self-identified diabetes prevalence rate between Adventist and non-
Adventist in pre-CHIP participants is significantly different. 
The dependent variable tracked in answering RQ1 was self-identified diabetes. 
The independent variables were religiosity and testing period. The five covariates were: 
age, gender, marital status, BMI, and parental death from diabetes before age 60. The 
quantitative test used to answer this question was logistic regression. 
To answer RQ1, I conducted a logistic regression analysis to investigate whether 
there was a significant difference in the self-identified preprogram diabetes rate between 
Adventists and non-Adventists, while controlling the effects of the covariates of age, 
gender, marital status, BMI, and parental death from diabetes before age 60. RQ1 dealt 
solely with the preprogram data and involved comparing Adventists and non-Adventists. 
Logistic regression determined whether religious affiliation predicted the dichotomous 
dependent variable of whether a subject had preprogram diabetes. Using logistic 




variable, the independent variables were categorical dichotomous, while the covariates 
are continuous variables either measured as intervals or ratios. The value of a continuous 
variable is not limited to a certain range, but rather continuous within a certain interval. A 
level of significance of 0.05 was used in the hypothesis testing. 
Research Question 2 (RQ2): After controlling for the effects of age, gender, 
marital status, and parental death from diabetes before age 60, is there a statistically 
significant difference in the change in biometric outcomes (TC, HDL, LDL, TG, FPG, 
SBP, DBP, and BMI) between Adventists and non-Adventists with self-identified 
diabetes pre- and post-CHIP between January 2006 and September 2012? 
H02: There is no statistically significant difference in biometric outcomes 
between Adventists and non-Adventists with self-identified type 2 diabetes pre- and post-
CHIP. 
H12: There is a statistically significant difference in biometric outcomes between 
Adventists and non-Adventists with self-identified type 2 diabetes pre- and post-CHIP. 
The dependent variables tracked in answering RQ2 were TC, HDL, LDL, TG, 
FPG, SBP, DBP, and BMI. The independent variables were religiosity and testing period. 
The covariates were age, gender, marital status, and parental death from diabetes before 
age 60. The quantitative test used to answer RQ2 was MANOVA. 
To answer RQ2, I conducted a repeated measures MANOVA. This test was 
performed to determine whether the dependent variables of the biometric outcomes were 
significantly different across the independent variables of religiosity with diabetes and 




A repeated measures MANOVA was used because the independent variables were 
categorically measured and had more than two identified groups. This approach was also 
used because there were multiple dependent variables determining the effects of the 
covariates (Babbie, 2012). The repeated measures MANOVA determined whether there 
were differences between independent groups on more than one dependent variable while 
also examining the difference between the preintervention and postintervention 
measurements of the participants.  
The independent variables in the repeated measures MANOVA were religiosity 
with diabetes while the repeated measure was the testing period. The dependent variables 
included the biometric measurements of TC, HDL, LDL, TG, FPG, SBP, DBP, and BMI, 
as well as the covariates of age, gender, marital status, and parental death from diabetes 
prior to age 60. The repeated measures MANOVA determined whether the religiosity 
with diabetes and testing period significantly accounted for variations in the biometric 
outcomes, while controlling for the influences of age, gender, marital status, and parental 
death from diabetes prior to age 60. The analysis of multiple independent variables, 
dependent variables, and covariates was included in one repeated measures MANOVA 
analysis in order to compare the effects of various independent variables on the 
dependent variables. In addition, the repeated measure as represented by the variable 
testing period on the dependent variables was also investigated to determine whether the 
effects of religiosity with diabetes on dependent variables were significantly different in 




The effect examination for the repeated measure of the testing period determined 
whether the CHIP intervention had an effect on the biometrics. A significance level of 
0.05 was used in the analyses. There was a significant difference or relationship if the p-
value was less than or equal to the level of the significance value. In instances wherein 
the repeated measures MANOVA determined significant relationships between 
independent and dependent variables, a post hoc Tukey’s test of multiple comparisons 
was conducted to further identify the relationships. 
Threats to Validity 
This study had very few threats to validity; the data obtained from this known 
database has been extensively used in previous research involving chronic disease risk 
factors (Kent et al., 2013b; Kent et al. 2014; Morton et al., 2014a; Morton et al., 2014b; 
Rankin et al., 2012). One of the threats to the external validity of the study was 
nonresponse bias because it could affect generalizing to other populations, wherein the 
data set of samples is not complete because some of the information from the study 
variables was missing. The threat caused a slight decrease in the sample size. As a result, 
this study involved a reasonable number of samples computed from the power analysis. It 
was ensured that all of the data for each of the study variables collected from the CHIP 
database were complete. The number of samples collected was greater than the minimum 
of 66 data sets required to set a certain allowance. 
Ethical Procedures 
This study was reviewed and approved by members of the Walden’s Institutional 




were used in this study and the data were preexisting and previously gathered, it was not 
necessary to use informed consent forms, nor were there ethical concerns. However, 
permission to use and access the CHIP database was obtained prior to its use in the study. 
It was important to ensure the confidentiality and anonymity of the individual data 
considered in the study and no identifiable information was obtained or used in this 
study. All of the data sets from the samples obtained from the database was coded to 
ensure that each individual’s responses remained unidentifiable; all data came to me 
deidentified. 
All data gathered in this study will be kept in a username and password-protected 
computer, which will only be accessed by me. Data obtained from the database will be 
stored for a minimum of five years per Walden’s procedure. Any data stored on a hard 
drive will be electronically deleted after five years. I had no conflicts of interest related to 
this study, and no incentives were used in this study. 
Summary 
Chapter 3 included a discussion of the research design, population, sampling and 
sampling procedures, instrumentation and operationalization of constructs, data collection 
procedures and recruitment of participants, data analysis plan, threats to validity, and 
ethical procedures. This study involved a quantitative research design with the objective 
of determining relationships between religiosity and preprogram diabetic state and 
religiosity with diabetic disease state and biometric outcomes. Secondary data were used 
from the CHIP database to obtain information on the pre- and post-CHIP measurements 




variables, and the covariates. Data analysis in SPSS version 23.0 included descriptive 
statistics, logistic regression, and MANOVA, which addressed the research questions of 




Chapter 4: Results 
Introduction 
The purpose of this quantitative correlational study was to determine the 
relationship between religious affiliation and preprogram diabetic state, and comparing 
religiosity and biometric outcomes in those with type 2 diabetes pre- and post-CHIP. This 
study utilized a secondary data set from CHIP to investigate if there was a significant 
difference in the self-identified preprogram diabetic state between Adventists and non-
Adventists, and examined how a particular religious affiliation (Adventist or non-
Adventist) in those with type 2 diabetes affected eight biometric outcomes pre- and post-
CHIP intervention. The study data were analyzed using logistic regression analysis and a 
repeated measures MANOVA to address the two primary research questions. The 
following research questions and hypotheses guided the analysis for this study: 
Research Question 1 (RQ1): After controlling the effects of age, gender, marital 
status, BMI, and parental death from diabetes before age 60, is there a statistically 
significant difference in self-identified type 2 diabetes prevalence rates between 
Adventist and non-Adventist CHIP participants preprogram between January 2006 and 
September 2012? 
H01: The self-identified diabetes prevalence rate between Adventist and non-
Adventist in pre-CHIP participants is not significantly different. 
H11: The self-identified diabetes prevalence rate between Adventist and non-




Research Question 2 (RQ2): After controlling for the effects of age, gender, 
marital status, and parental death from diabetes before age 60, is there a statistically 
significant difference in the change in biometric outcomes (TC, HDL, LDL, TG, FPG, 
SBP, DBP, and BMI) between Adventists and non-Adventists with self-identified 
diabetes pre- and post-CHIP between January 2006 and September 2012? 
H02: There is no statistically significant difference in biometric outcomes 
between Adventists and non-Adventists with self-identified type 2 diabetes pre- and post-
CHIP. 
H12: There is a statistically significant difference in biometric outcomes between 
Adventists and non-Adventists with self-identified type 2 diabetes pre- and post-CHIP. 
In overview, this chapter addresses the research questions and the statistical 
analysis results by section. First, the demographic information is provided for the CHIP 
samples; second, the descriptive statistics of study variables are provided; third, the 
statistical tests are discussed for RQ1 and RQ2; fourth, the logistic regression analysis 
and repeated measures MANOVA are presented for each biometric pre- and 
postprogram.  
Data Collection 
The population of respondents consisted of 7,172 self-selected Adventists and 
non-Adventists that attended the CHIP program between January 2006 and September 
2012. There were no discrepancies in data collected to the plan presented in chapter 3. 
The frequency and percentage summaries of the participants’ demographic variables of 




diabetes prior to age 60 are summarized in Table 2. Of the total 7,172 CHIP participants, 
14.6% (1,036) self-identified themselves as having been told by a physician they had 
diabetes; 21.2% (1,523) self-identified Adventist affiliation; 78.8% (5,649) self-identified 
as non-Adventist. There were more married participants (64.3%; 4,614) than single, 
divorced, or widowed (22.5%; 1,612), and 66.6% (4,774) were women. Two hundred and 
thirty-three (3.2%) participants reported a history of parental death from type 2 diabetes 
before age 60. Descriptive statistics of mean and standard deviation were used to 
summarize the data regarding age (Table 3). The average age of the population was 57.38 
years (SD = 13.01), ranging from 9 to 103, with 86 participants under 18 years old. Two 
hundred and ten (210) Adventists self-identified as having diabetes preprogram, 
compared to 836 non-Adventists (see Table 4). No participants under 18 years old were 





Frequency and Percentage Summaries of Demographic Information (N = 7,172) 
 Category          n        % 
Self-identified preprogram diabetic state    
No previous history with diabetes 6,126 85.4 
Previous history with diabetes 1,036 14.5 
Missing 10  0.1 
Religiosity self-identified affiliation as a Seventh-day Adventist      
Non-Adventist  5,649 78.8 
    Adventist 1,523 21.2 
Gender     
Male 2,394 33.4 
Female 4,774 66.6 
Missing 4 <0.1 
Marital Status     
Single, divorced, widowed 1,612 22.5 
Married 4,614 64.3 
Missing 946 13.2 
Parental death from type 2 diabetes before age 60     
With family history 233 3.2 
No family history 4,399 61.3 




Descriptive Statistics Summaries of Age (N = 7,172) 
       N     Minimum    Maximum       M SD 







Cross Tabulation of Religiosity and Self-Identified Preprogram Diabetic State (N = 
6,126) 
 Religious affiliation 
Self-identified preprogram diabetic 
state  Total 
No Yes 
    n % n % n % 
Religiosity self-identified 
affiliation as Seventh-day 
Adventist  
Non-Adventist  4,783 78.1 836 79.9 5,619 78.3 
Adventist  1,343 21.9 210 20.1 1,553 21.7 
Total 6,126 100.0 1,046 100.0 7,172 100.0 
 
Results 
Descriptive Statistics of Study Variables  
Table 5 summarizes the descriptive statistics of the study variables. Descriptive 
statistics of means and standard deviation were used to summarize the data of the 
continuous-measured study variables, which were the dependent variables of the 
biometric outcomes (TC, HDL, LDL, TG, FPG, SBP, DBP, and BMI). The statistics 
included the summaries of the responses in the self-reported medical and lifestyle 
prequestionnaire and the pre- and postassessment questionnaire.  
The comparison of the pre- and postprogram assessment showed that all 
biometrics of the population mean change were lower after completing CHIP. The largest 
improvements were seen in those who resided in the highest risk category except LDL. 
From pre- to postclass, the largest mean change reductions were seen in the TG outcomes 
from 639.61 to 629.11 (-10.50 mg/dl), FPG from 165.86 to 156.66 (-6.12 mg/dl), TC 
from 309.46 to 305.46 (-4.01 mg/dl), DBP from 110.66 to 107.53 (-3.13 mmHg), and 




mean and 36.42 postclass mean) were in the ≥30 BMI category both preprogram 
(n=3534/49.3%) and postprogram (n=2860/39.9%). The largest mean change in LDL 
were those within the normal range and dropped their mean change by -3.39 mg/dl (79.37 
to 75.98). From pre- to postclass, 14.8% more participants met the normal criteria for TC, 
an additional 12.3% met the normal criteria for LDL, 5.0% more met the criteria for a 
normal FPG, 9.6% more met the normal criteria for a normal SBP, 11.4% more met the 
normal criteria for DBP, an additional 2.9% met the normal BMI criteria, 7.7% less 
participants met the criteria for a normal HDL, and 0.4 less participants met the normal 





Table 5  
Descriptive Statistics Scores of Pre- and Postprogram Biometric Outcomes Categorized 
by Disease Risk Factor (n=7,172) 
Risk Factor Preprogram Postprogram Preprogram Postprogram Mean change (95% 
confidence interval) (%) 
  n (%) n (%) (Mean + SD) (Mean + SD) 
Total cholesterol, mg/dl    
<160 1550 (21.6) 2611 (36.4) 139.42 + 16.00 135.96 + 17.17 -3.46 (5.57, 7.68) (-2.48) 
160-199 2689 (37.5) 2585 (38.9) 180.06 + 11.25 178.33 + 11.31  -1.72 (15.62, 17.29) (-0.96) 
200-239 1976 (27.6) 1148 (17.3)  217.20 + 11.25 215.37 + 10.91  -1.83 (26.07, 28.29) (-0.84) 
240-280 721(10.1) 256 (3.39) 255.07 + 10.91 254.47 + 10.83  -0.60 (37.50, 42.05) (-0.24) 
>280 182 (2.5) 42 (0.6) 309.46 + 34.81 305.46 + 21.40 -4.01 (53.23, 68.14) (-1.30) 
High-density lipoproteins, mg/dl    
<40 3397 (47.4) 4073 (56.8) 37.99 + 6.88 37.12 + 6.99 -0.87 (1.52, 1.91) (-2.28) 
40-60 2252 (31.4) 1699 (23.7) 50.76 + 5.52 50.72 + 5.60 -0.04 (4.08, 4.66) (-0.07) 
>60 1465 (20.4) 867 (12.1) 71.21 + 11.82 69.48 + 10.41 -1.73 (8.86, 9.94) (-2.43) 
Low-density lipoproteins, mg/dl    
<100 2392 (33.4) 3275 (45.7) 79.37 + 15.48  75.98 + 16.46 -3.39 (4.01, 5.52) (-4.28) 
100-129 2299 (32.1) 2118 (29.5) 114.17 + 8.60  113.24 + 8.40 -0.93 (12.21, 13.84) (-0.82) 
130-159 1520 (21.2) 895 (12.5) 142.48 + 8.50  141.87 + 8.51  -0.61 (21.30, 23.55) (-0.43) 
160-190 576 (8.0) 222 (3.1) 171.14 + 8.1 171.02 + 8.06  -0.12 (29.21, 33.32) (-0.07) 
>190 213 (3.0) 59 (0.8) 209.61 + 21.04 209.10 + 23.43  -0.52 (41.84, 50.80) (-0.25) 
Triglycerides, mg/dl    
<150 4629 (64.5) 4597 (64.1) 94.67 + 29.95  94.54 + 29.37 -0.13 (-5.84, -3.80) (-0.14) 
150-199 1184 (16.5) 1075 (15.0) 171.56 + 13.81  171.47 + 14.22  -0.09 (11.08, 17.10) (-0.05) 
200-500 1233 (17.2) 950 (13.2) 269.99 + 62.76  265.23 + 60.51  -4.76 (46.67, 55.55) (-1.76) 
>500 60 (0.8) 15 (0.2) 639.61 + 118.10  629.11 + 85.70  -10.50 (237.83, 340.28) (-
1.64) 
Fasting plasma glucose, mg/dl    
<110 4534 (63.2) 4891 (68.2) 87.61 + 7.90 86.61 + 7.94 -1.00 (0.56,1.13) (-1.14) 
110-125 1708 (23.8) 1270 (17.7) 108.40 + 6.91  108.06 + 6.93 -0.33 (7.13, 8.31) (-0.31) 
>125 835 (11.6) 464 (6.5) 165.86 + 44.23  156.66 + 32.79  -6.12 (29.16, 34.29) (-5.54) 
Systolic blood pressure, mmHg    
<120 1563 (21.8) 2251 (31.4) 110.16 + 7.29 109.60 + 7.52 -0.56 (-2.71, -1.51) (-0.51) 
120-139 3047 (42.5) 2959 (41.3) 128.73 + 5.85  127.97 + 5.75  -0.76 (4.44, 5.32) (-0.59) 
140-160 1831 (25.5) 1121 (15.6) 147.94 + 6.43 147.01 + 6.23  -0.93 (12.88, 14.20) (-0.63) 
>160 564 (7.9) 193 (2.7) 173.80 + 12.06 172.45 + 9.70  -1.35 (23.58, 26.93) (-0.78) 




Table 5  
Descriptive Statistics Scores of Pre- and Postprogram Biometric Outcomes Categorized 
by Disease Risk Factor (n=7,172)  
Risk Factor Preprogram Postprogram Preprogram Postprogram Mean change (95% 
confidence interval) (%) 
  n (%) n (%) (Mean + SD) (Mean + SD) 
Diastolic blood pressure, mmHg    
<80 3285 (45.8) 4101 (57.2) 70.49 + 6.41 69.79 + 6.76  -0.70 (-0.74, -0.08) (-0.99) 
80-89 2366 (33.0) 1872 (26.1) 83.22 + 2.93  82.81 + 2.81  -0.41 (5.64, 6.33) (-0.49) 
90-100 1171 (16.3) 501 (7.0) 93.69 + 3.56  93.12 + 3.36  -0.57 (10.20, 11.22) (-0.61) 
>100 180 (2.5) 49 (0.7) 110.66 + 14.72  107.53 + 7.84  -3.13 (18.41, 24.42) (-2.83) 
Body mass index, Kg/m²    
<18.5 51 (0.7) 46 (0.6) 17.54 + 0.90  17.65 + 0.75  0.11 (-0.01, 0.33) (0.62) 
18.5-24.9 1347 (18.8) 1555 (21.7) 22.68 + 1.63  22.66 + 1.64  -0.02 (0.43, 0.53) (-0.10) 
25-29.9 2109 (29.4) 2049 (28.6) 27.48 + 1.41  27.47 + 1.43  -0.01 (0.84, 0.90) (-0.05) 
≥30 3534 (49.3) 2860 (39.9) 36.82 + 6.19  36.42 + 5.96  -0.40 (1.26, 1.33) (-1.07) 
 
Normality Testing  
Prior to conducting the statistical analysis, statistical assumptions for normality of 
the study variables on the population were tested to ensure that the data followed normal 
distribution. Normality testing was only conducted on the study variables that were 
continuously measured. These included the dependent variables of the biometrics (TC, 
HDL, LDL, TG, FPG, SBP, DBP, and BMI) and age. The histograms for normality 
testing on the population are presented in Appendix B.  
Each study variable histogram distribution formed a bell-shaped curve pattern, 
representing a normal distribution. Although the bell-shaped pattern formed in each of 
the graphs was not a perfect representation, this is considered acceptable. Each biometric 




the study variables was not violated. 
Logistic Regression Results for Research Question One (RQ1) 
The following research question guided this analysis: 
RQ1: After controlling the effects of age, gender, marital status, BMI, and 
parental death from diabetes before age 60, is there a statistically significant difference in 
self-identified type 2 diabetes prevalence rates between Adventist and non-Adventist 
CHIP participants preprogram between January 2006 and September 2012?  
H01: The self-identified diabetes prevalence rate between Adventist and non-
Adventist in pre-CHIP participants is not significantly different. 
H11: The self-identified diabetes prevalence rate between Adventist and non-
Adventist in pre-CHIP participants is significantly different. 
The dependent variable tracked in answering RQ1 was self-identified diabetes. 
The independent variables were religiosity and testing period. Five covariates were also 
tracked: age, gender, marital status, BMI, and parental death from diabetes before age 60. 
The quantitative test used to answer this question was logistic regression. 
A logistic regression analysis was performed to investigate whether there was a 
significant difference in the self-identified preprogram diabetic state between Adventists 
and non-Adventists, while controlling for the covariate effects of age, gender, marital 
status, BMI, and parental death from diabetes before age 60. The dependent variable of 
self-identified diabetic state was a dichotomously measured variable with the binary 
codes of 0 (no previous history with diabetes) and 1 (previous history with diabetes). 




of diabetes pre-CHIP program. A level of significance of 0.05 was used in the analysis. 
The self-identified diabetes state between Adventists and non-Adventists would be 
significantly related if the p-value of the effect of religion were less than or equal to the 
level of significance value of 0.05. 
The logistic regression model generated was a two-step approach. The first step 
determined the effects of the covariates of age, gender, body mass index, marital status, 
and parental death from type 2 diabetes before age 60, on the self-identified diabetes 
state. The second step determined the effects of the independent variables of religiosity 
and testing period on the diabetes state, while controlling for the effects of the covariates 
of age, gender, marital status, BMI, and parental death from diabetes before age 60. The 
covariates and the independent variables were treated as categorical variables in the 
logistic regression model. Table 6 summarizes the logistic regression results with 
confidence intervals and odds ratios 
For step 1, the results showed that all of the covariates of age (Wald (1) = 191.55, p 
< 0.001), gender (Wald (1) = 19.28, p < 0.001), BMI (Wald (1) = 494.16, p < 0.001), 
marital status (Wald (1) = 16.34, p < 0.001), and parental death from diabetes before age 
60 (Wald (1) = 165.30, p < 0.001) have significant effects on the dependent variable of 
self-selected diabetic state. This suggested that there is a significant difference in the 
preprogram diabetic state of the sample when there are differences in these covariates.  
For step 2, the results showed that the independent variables of religiosity (Wald 
(1) = 0.30, p = 0.58) and testing period (Wald (1) = 2.08, p = 0.15) did not have a 




covariates. Therefore, the self-identified diabetes state between Adventists and non-
Adventists pre-CHIP was not significantly different. The results of the logistic regression 
failed to reject the null hypothesis for RQ1. The odds ratio of religiosity was 0.96 and the 
odds ratio of testing period was 0.91. The effects of religiosity and testing period were 
insignificant. The odds or probability of having preprogram diabetic state cannot be 




Table 6  
Logistic Regression Results of Effects of Diabetes State (n = 7,172) 
                
95% C.I.for 
EXP(B) 
 Step  Variable B SE Wald df Sig. 
Exp 
(B) /Odd 
Ratio Lower Upper 
Step 1  Age 0.04 0.00 191.55 1 0.00* 1.04 1.03 1.05 
Gender (1) 0.29 0.07   19.28 1 0.00* 1.34 0.66 0.85 
Body mass index  0.09 0.00 494.16 1 0.00* 1.10 1.09 1.11 
Marital status (1) 0.29 0.07   16.34 1 0.00* 1.33 0.66 0.87 
Parental death 
from type 2 
diabetes before 
age 60 (1) 
1.45 0.11 165.30 1 0.00* 4.27 0.19 0.29 
Constant -7.07 0.24 838.37 1 0.00* 0.00   
Step 2 Religiosity self-
selected 
affiliation as a 
Seventh-day 
Adventist (1) 
-0.04 0.08 0.30 1 0.58 0.96 0.90 1.21 
Testing period 
(1) 
-0.09 0.06 2.08 1 0.15 0.91 0.97 1.24 
Constant -7.03 0.25 818.75 1 0.00* 0.00     
Notes. Variable(s) entered on Step 1: Age, Gender, Body Mass Index (BMI), Marital Status, 
Parental death from type 2 diabetes before age 60. Independent Variable(s) entered on Step 2: 
Religiosity self-identified affiliation as a Seventh-day Adventist, Testing period. Dependent 
Variable: Diabetes State. *Significant at level of significance of ≤ 0.05 
 
 
Repeated Measures MANOVA Results for Research Question Two (RQ2) 
 The following research question guided this analysis: 
RQ2: After controlling for the effects of age, gender, marital status, and parental 
death from diabetes before age 60, is there a statistically significant difference in the 




Adventists and non-Adventists with self-identified diabetes pre- and post-CHIP between 
January 2006 and September 2012? 
H02: There is no statistically significant difference in biometric outcomes 
between Adventists and non-Adventists with self-identified type 2 diabetes pre- and post-
CHIP. 
H12: There is a statistically significant difference in biometric outcomes between 
Adventists and non-Adventists with self-identified type 2 diabetes pre- and post-CHIP. 
The dependent variables tracked in answering RQ2 were TC, HDL, LDL, TG, 
FPG, SBP, DBP, and BMI. The independent variables were religiosity and testing period. 
The covariates were age, gender, marital status, and parental death from diabetes before 
age 60. The quantitative test used to answer RQ2 was MANOVA. 
Table 7 summarized the descriptive statistics of all the biometric outcomes 
segregated between the Adventists with diabetes and non-Adventists with diabetes.  
The highest percentage of Adventists and non-Adventist entered and exited CHIP 
with a normal HDL, LDL, TG, FPG, and DBP. Adventists achieved a greater mean 
change reduction in TC (-5.37 vs. -4.28), SBP (-2.59 vs. -1.42), DBP (-1.25 vs. -0.79), 
and BMI (-0.42 vs. -0.26) than non-Adventists postclass. Non-Adventists achieved the 
greatest mean change reduction postclass in the highest risk category of HDL (-1.70 vs. -
0.48), LDL (-1.91 vs 7.87), TG (-68.34 vs. 11.0), and FPG (-12.74 vs. 6.12) over 
Adventists. Adventists achieved the greatest mean change reduction postclass in the 
highest risk category of TC (0.15 vs 3.27), SBP (-1.86 vs. -1.42), DBP (-1.25 vs. 1.95), 




the percentage of participants from pre- to postclass, and both groups increased the 
percentage of participants in the normal category in LDL, TG, TC, FPG, SBP, DBP, and 
BMI.     
Table 8 presents the results of the repeated measures MANOVA. This determined 
the main effect of whether the repeated measures statistics of the dependent variables of 
the biometric outcomes in the pretest and posttest were significantly different due to 
religious affiliation. It also determined whether the repeated measures and the between-
subject factor of religiosity have a two-way influence to each of the eight dependent 
variables. A repeated measures MANOVA was conducted to determine whether the 
dependent variables of the biometric outcomes were significantly different across the 
independent variables, while controlling for the effects of the covariates. The repeated 
measures MANOVA was performed to determine whether religiosity with diabetes and 
testing period significantly accounted for variations in the biometric outcome 
measurements. A level of significance of 0.05 was used in the MANOVA. Significant 
differences in biometric outcomes were observed if the p-value of the F statistics of the 
MANOVA was less than or equal to the level of significance set at 0.05. The within-
subject factor was the repeated measures scores or the testing periods (pretest and 
posttest), and the between-subject factor was religiosity (Adventist or non-Adventist). 
The interaction effects of the within-subject factor of the testing periods and the 
between-subject factor of religiosity had significant effects on the biometric outcomes of 
TC (F(1) = 5.65; p = 0.02) and LDL (F(1) = 5.76; p = 0.02). The interaction effects of the 




did not have any significant effects on the biometric outcomes of HDL (F(1) = 0.00; p = 
0.99), TG (F(1) = 0.19, p = 0.67), FPG (F(1) = 2.71, p = 0.10), SBP (F(1) = 2.25; p = 
0.13), DBP (F(1) = 1.20; p = 0.27), and BMI (F(1) = 1.65; p = 0.20). Only the biometric 
outcomes of TC and LDL between the Adventists with diabetes and non-Adventists with 
diabetes after they underwent the CHIP intervention were significantly different from the 
pretest to the posttest, and was due to religious affiliation. The hypothesis, “There is a 
significant difference in biometric outcomes between Adventists and non-Adventists with 
self-identified type 2 diabetes pre- and post-CHIP,” was supported by the results of the 
analysis, and therefore the null hypothesis for RQ2 was rejected. Although both groups 
improved in all the other biometrics pre- to post-CHIP, these improvements were not due 





Descriptive Statistics Scores of Pre- and Postprogram Biometric Outcomes Between Adventists (n=210) and Non-Adventists With 
Diabetes Categorized by Risk Factor Classification (n=836) 
  Adventists with diabetes Non-Adventists with diabetes 
 Baseline 30 d, Baseline 30 d, Mean change (95%  
confidence interval) 
 (%) 
Baseline 30 d, Baseline 30 d, Mean change 




n (%) n (%) (Mean + SD) (Mean + SD) n (%) n (%) (Mean + SD) (Mean + SD) 
High-density lipoproteins, mg/dl                 
<40 52 (24.9) 77 (36.8) 33.44 + 5.06 32.65 + 5.13 -0.78 (1.09, 3.51) (2.34) 237 (28.3) 323 (38.6) 32.67 + 4.85 32.60 + 5.05 -0.07 (-0.14, -
0.06) (0.21) 
40-60 100 (47.8) 99 (47.7) 49.51 +5.64 48.70 + 6.28 -0.81 (2.60, 4.84) (1.64) 412 (49.3) 391 (46.8) 49.15 + 5.78 48.22 + 5.80 -0.93 (2.99, 4.21) 
(1.89) 
>60 57 (27.3) 33 (15.8) 73.31 + 17.15 72.83 + 14.09 -0.48 (5.11, 11.36) (0.65) 187 (22.4) 122 (14.6) 73.40 + 11.81 71.70 + 11.02 -1.70 (7.21, 9.93) 
(2.32) 
Low-density lipoproteins, mg/dl          
<100 77 (36.8) 131 (62.7) 79.91 + 15.47 78.34 + 15.08 -1.58 (5.03, 11.65) (1.97) 336 (40.2) 463 (55.4) 78.92 + 16.79 74.23 + 16.74 -4.69 (-0.22, -
0.11) (5.94) 
100-129 57(27.3) 47 (22.5) 113.74 + 9.37 114.89 + 8.07 1.15 (15.13, 20.93) (-1.01) 265 (31.7) 248 (29.7) 114.25 + 8.63 112.04 + 8.20 -2.21 (0.32, 0.48) 
(1.93) 
130-159 45 (21.5) 20 (9.6) 142.18 + 8.96 143.50 + 9.46 1.32 (17.82, 29.95) (-0.93) 164 (19.6) 99 (11.8) 142.22 + 8.30 142.70 + 9.15 0.48 (0.78, 1.01) (-
0.34) 
160-190 22 (10.5) 8 (3.8) 171.44 + 8.60 169.50 + 8.68 -1.94 (15.11, 40.83) (1.13) 55 (6.6) 21 (2.5) 171.69 + 8.23 171.09 + 7.91 -0.60 (1.02, 1.52) 
(0.35) 




Triglycerides, mg/dl          
<150 127 (60.8) 147 (70.3) 89.84 + 32.14 94.87 + 30.64 5.03 (-12.68, -1.83) (-5.59) 531 (63.5) 592 (70.8) 93.62 + 29.73 95.64 + 29.84 2.02 (-9.68, -3.99) 
(-2.16) 








>500 2 (1) 1 (0.5) 639.00 + 59.40 650.00 (.) 11.00 (-2452.77, 2756.77)  
(-1.72) 











Descriptive Statistics Scores of Pre- and Postprogram Biometric Outcomes Between Adventists (n=210) and Non-Adventists With 
Diabetes Categorized by Risk Factor Classification (n=836)  
  Adventists with diabetes Non-Adventists with diabetes 
 Baseline 30 d, Baseline 30 d, Mean change (95%  
confidence interval) 
 (%) 
Baseline 30 d, Baseline 30 d, Mean change 




n (%) n (%) (Mean + SD) (Mean + SD) n (%) n (%) (Mean + SD) (Mean + SD) 
Total cholesterol, mg/dl          
<160 44 (21.1) 90 (43.1) 137.14 + 17.97 135.94 + 17.78 -1.20 (2.31, 13.35) (0.87) 201 (24) 367 (43.9) 138.49 + 
16.90 
134.21 + 17.82 -4.28 (0.89, 7.58) 
(3.09) 
160-199 65 (31.1) 77 (36.8) 179.10 + 11.12 178.08 + 11.82 -1.02 (15.64, 25.52) (0.57) 325 (38.9) 297 (35.5) 180.49 + 
11.53 
177.30 + 11.07 -3.19 (15.11, 
20.01) (1.77) 
200-239 67 (32.1) 28 (13.4) 218.00 + 11.31 215.69 + 11.21 -2.31 (23.95, 34.85) (1.06) 224 (26.8) 143 (17.1) 217.13 + 
11.11 
215.41 + 10.84 -1.72 (24.08, 
30.67) (0.79) 
240-280 23 (11) 10 (4.8) 257.47 + 9.29 252.10 + 10.27 -5.37 (26.81, 62.52) (2.09) 69 (8.3) 26 (3.1) 254.55 + 
10.92 
253.70 + 10.47 -0.85 (30.09, 
41.92) (0.33) 
>280 10 (4.8) 4 (1.9) 307.60 + 30.29 307.75 + 28.63 0.15 (25.19, 80.61) (-0.05) 17 (2.0) 3 (0.4) 297.40 + 
14.16 
300.67 + 10.41 3.27 (28.81, 
80.88) (-1.10)  
Fasting plasma glucose, mg/dl          
<110 166 (79.4) 178 (85.2) 91.52 + 8.30 89.05 + 9.08 -2.46 (0.63, 3.50) (2.69) 663 (79.3) 731 (87.4) 91.65 + 9.19 90.20 + 9.13 -1.45 (22.95, 
39.54) (1.58) 
110-125 166 (8.1) 17 (8.1) 115.53 + 4.17 115.82 + 4.11 0.29 (3.79, 15.83) (-0.25) 78 (9.3) 40 (4.8) 116.59 + 4.49 115.79 + 4.68 -0.80 (3.26, 
12.02) (0.69) 
>125 166 (12.4) 14 (6.7) 175.81 + 72.66 181.93 + 65.54 6.12 (11.94, 45.40) (-3.48) 95 (11.4) 65 (7.8) 170.99 + 
47.60 
158.25 + 33.24 -12.74 (22.95, 
39.54) (7.45) 
Systolic blood pressure, mmHg          
<120 50 (23.9) 93 (44.5) 111.51 + 6.74 108.92 + 7.88 -2.59 (-0.40, -0.12) (2.32) 207 (24.8) 349 (41.7) 110.60 + 7.79 109.76 + 7.59 -0.84 (-0.39, -
0.25) (0.76) 
120-139 83 (39.7) 83 (39.7) 129.41 + 5.86 128.08 + 6.06 -1.33 (0.22, 0.50) (1.03) 350 (41.9) 339 (40.6) 129.04 + 5.95 128.43 + 5.90 -0.61 (0.24, 0.38) 
(0.47) 
140-160 55 (26.3) 26 (12.4) 146.71 + 5.63 147.73 + 6.21 1.02 (0.76, 1.20) (-0.70) 205 (24.5) 125 (15) 148.22 + 6.22 147.37 + 6.33 -0.85 (14.27, 
18.47) (0.57) 
>160 21 (10) 7 (3.3) 173.43 + 7.85 171.57 + 12.25 -1.86 (0.94, 1.82) (1.07) 74 (8.9) 23 (2.8) 174.68 + 
12.41 
173.26 + 7.88 -1.42 (1.05, 1.47) 
(0.81) 
 





Descriptive Statistics Scores of Pre- and Postprogram Biometric Outcomes Between Adventists (n=210) and Non-Adventists With 
Diabetes Categorized by Risk Factor Classification (n=836)  
  Adventists with diabetes Non-Adventists with diabetes 
 Baseline 30 d, Baseline 30 d, Mean change (95%  
confidence interval) 
 (%) 
Baseline 30 d, Baseline 30 d, Mean change 




n (%) n (%) (Mean + SD) (Mean + SD) n (%) n (%) (Mean + SD) (Mean + SD) 
Diastolic blood pressure, mmHg          
<80 117 (56) 145 (69.4) 69.07 + 7.04 70.15 + 6.44 1.08 (-3.77, -0.13) (-1.56) 430 (51.4) 572 (68.4) 70.11 + 6.70 70.17 + 6.46 0.06 (-0.21, -
0.13) (-0.09) 
80-89 57 (27.3) 52 (24.9) 83.37 + 2.87 83.38 + 2.97 0.01 (3.38, 7.32) (-0.01) 270 (32.3) 202 (24.2) 83.36 + 2.76 82.94 + 2.73 -0.42 (0.46, 0.61) 
(0.50) 
90-100 31 (14.8) 11 (5.3) 93.48 + 3.19 92.36 + 3.20 -1.12 (8.77, 15.44) (1.20) 114 (13.6) 60 (7.2) 93.87 + 3.34 93.08 + 3.24 -0.79 (0.92, 1.22) 
(0.84) 
>100 4 (1.9) 1 (0.5) 104.25 + 2.87 103.00 (.) -1.25 (-4.93, 41.43) (1.20) 22 (2.6) 2 (0.2) 107.55 + 7.04 109.50 + 2.12 1.95 (1.52, 2.29) 
(-1.81) 
Body mass index, Kg/m²          




38 (18.2) 44 (21.1) 22.48 + 1.85 22.45 + 1.86 -0.04 (-0.04, 0.20) (0.17) 154 (18.4) 194 (23.2) 22.69 + 1.46 22.59 + 1.54 -0.10 (-0.05, 
0.05) (0.44) 
25-29.9 67 (32.1) 64 (30.6) 27.90 + 1.70 27.84 + 1.74 -0.06 (0.22, 0.44) (0.21) 284 (34.0) 275 (32.9) 27.83 + 1.72 27.87 + 1.77 0.04 (0.22, 0.35) 
(-0.14) 











Type III Sum 
of Squares 
   
df   MS F  Sig. 
Testing Period TC Linear 275.82 1 275.82 0.83 0.36 
HDL Linear 54.10 1 54.10 2.14 0.14 
LDL Linear 463.85 1 463.85 1.71 0.19 
TG Linear 1072.83 1 1072.83 0.66 0.42 
FPG Linear 27.45 1 27.45 0.18 0.68 
SBP Linear 73.01 1 73.01 0.59 0.44 
DBP Linear 0.20 1 0.20 0.00 0.95 
BMI Linear 2.14 1 2.14 2.79 0.10 
 
 
Testing Period * Religiosity 
self-identified affiliation as 



















HDL Linear 0.00 1 0.00 0.00 0.99 
LDL Linear 1558.66 1 1558.66 5.76 0.02* 
TG Linear 300.80 1 300.80 0.19 0.67 
FPG Linear 421.89 1 421.89 2.71 0.10 
SBP Linear 280.07 1 280.07 2.25 0.13 
DBP Linear 59.37 1 59.37 1.20 0.27 
BMI Linear 1.27 1 1.27 1.65 0.20 
 









    
HDL Linear 14115.78 559 25.25     
LDL Linear 151283.83 559 270.63     
TG Linear 905897.16 559 1620.57     
FPG Linear 86955.29 559 155.56     
SBP Linear 69443.99 559 124.23     
DBP Linear 27634.27 559 49.44     






This study aimed to compare religious affiliation and how each affected biometric 
outcomes pre- and post-CHIP intervention in those with type 2 diabetes, and to assess if 
Adventists or non-Adventists entered CHIP with different prevalent rates of diabetes. The 
specific data analyses conducted include descriptive statistics, logistic regression 
analysis, repeated measures MANOVA, and frequency and percentages.  
The results of the logistic regression analysis showed that religious affiliation and 
testing period did not have a significant effect on the self-identified preprogram diabetes 
rate once step two was completed. The results of the logistic regression failed to reject the 
null hypothesis for RQ1. The results of the repeated measures MANOVA showed that the 
interaction effects of the within-subject factor of the testing periods and the between-
subject factor of religiosity had significant effects on the biometric outcomes of TC and 
LDL. The null hypothesis for RQ2 was rejected; there was a significant difference in 
biometric outcomes for TC and LDL between Adventists and non-Adventists with self-
identified type 2 diabetes pre- and post-CHIP, which were due to Adventist affiliation. 
Pre- and post-CHIP Adventists had a higher TC and LDL than non-Adventists. When 
compared to non-Adventists, having an Adventist affiliation revealed little difference pre- 
and post-CHIP in both the percentage of members who fell within the highest risk factor 




Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The current standard U.S. dietary recommendations to prevent and reverse 
diabetes do not address the root cause of diabetes; instead, diabetes is commonly 
managed in the United States through medications and moderation of all foods, 
regardless of their health value (ADA, 2016). A whole-food, plant-based, vegan diet 
addresses the root cause of diabetes and can reverse and prevent this disease (Yokoyama 
et al., 2014). A diet higher in animal protein increases the risk of diabetes while a diet 
higher in vegetable protein reduces the risk (Malik, Li, Tobias, Pan & Hu, 2016; 
Viguiliouk et al., 2015), with no threshold when further reduction of animal products 
does not help (Campbell, Parpia, & Chen, 1998). This study addressed a gap in the 
literature by assessing if having a particular religious affiliation had an influence on 
biometric outcomes pre- and post-CHIP, a plant-based, vegan intervention program. The 
purposes of this study were to determine the relationship between religiosity and 
preprogram diabetes state, and to determine if there was a statistically significant 
difference in the biometric changes between Adventists and non-Adventists with diabetes 
pre- and post-CHIP in those with type 2 diabetes.    
The logistic regression analysis in RQ1 failed to reject the null hypothesis. The IV 
of religiosity and testing period did not have a significant effect on the self-identified 
diabetes state between Adventists and non-Adventists, after controlling for the covariates. 
The reported diabetes rates—78.8% of non-Adventists and 21.2% of Adventists—was 




rejected. In RQ2, the repeated MANOVA analysis showed that biometric outcomes 
between Adventists with diabetes and non-Adventists with diabetes were significantly 
different due to religious affiliation in LDL and TC pre- and post-CHIP and therefore 
rejected the null hypothesis. Both groups improved in the percentage of participants who 
moved into the normal category for all biometrics. Both groups reduced the percentage of 
participants who were in the highest risk category.    
Interpretation of the Findings 
Previous CHIP research has presented pre- and postbiometrics in general and in 
gender differences (Kent et al., 2014; Morton et al., 2014a) but not in religious 
differences. During the latter part of finishing this dissertation, Kent et al. (2015), 
published new research that assessed biometric changes among religious affiliation 
(Adventist and non-Adventist) pre- and post-CHIP. They reported that Adventists and 
non-Adventists achieved similar biometric improvements post-CHIP though non-
Adventists improved in more areas, and those who were in the greatest risk categories 
improved the most, similar to previous CHIP findings (Kent et al., 2015). Though my 
current research additionally targeted those with type 2 diabetes in addition to Adventist 
affiliation, Kent at al. (2015), found similar outcomes; this shows that regardless of 
participant’s Adventist or diabetes status, they can see improvements at the post-CHIP 
intervention stage. 
This study also showed that the self-identified diabetes state between Adventist 
and non-Adventist in pre-CHIP participants was not found to be significantly different, 




not surprising considering CHIP targets those with diabetes and other chronic diseases 
and Adventists may be drawn to an Adventist health program. This group of Adventists 
would not be representative of the entire denomination. 
The present study showed that having a particular religious belief, either 
Adventist or non-Adventist with diabetes, did elicit significant improvement differences 
in LDL and TC pre- and post-CHIP and was due to religious affiliation. The other 
biometrics improved also, but was due to factors other than religion, and may be due to 
lifestyle factors not currently captured in the CHIP questionnaires, such as gender, 
income, readiness to learn, and changes in medication, diet, and exercise. Adventists with 
diabetes had a higher mean in the normal category preprogram for FPG and DBP.  
Non-Adventists had a higher mean in the normal disease risk category 
preprogram for HDL, LDL, TG, TC, SBP, and BMI. Postclass Adventists had a higher 
mean in the normal category for HDL, LDL, SBP, and DBP. Non-Adventists had a 
higher mean in the normal category for TG, TC, FPG, and BMI. Adventists had a higher 
percentage of participants in the highest category preclass in HDL, LDL, TG, TC, FPG, 
SBP, and BMI. Non-Adventists had a higher percentage of participants in the highest 
preclass in DBP. Postclass Adventists had a higher percentage of participants in the 
highest category in HDL, LDL, TG, TC, SBP, and DBP, where non-Adventists were 
higher in BMI and FPG. Adventists made a greater mean change reduction in the highest 
disease risk category in SBP, DBP, and BMI, and non-Adventists in HDL, LDL, TG, and 
FPG. In the highest category, Adventists increased their postclass mean change LDL by 




increased their postclass mean change TC by 3.27 and DBP by 1.95. Both groups 
increased the percentage of participants who entered into a lower HDL category.    
The literature review presented evidence showing the effectiveness of a 
comprehensive plant-based, lifestyle program in the reduction of chronic disease such as 
diabetes and cardiovascular disease, and has the potential to impact large numbers of 
people while reducing health costs significantly (Shurney et al., 2012). Despite the lack 
of a control group and selection bias, this study, with its large sample size, indicated that 
the volunteer-delivered CHIP modification intervention program is an effective 30-day, 
community-based, video-presented, plant-based, lifestyle program (Morton et al., 2014a). 
The literature review pointed out that trained volunteers have improved health 
indicators for chronic disease such heart failure (Siabani et al., 2014), CVD risk factors 
(Rankin et al., 2012), and at-home exercise programs (Castro, Pruitt, Buman, & King, 
2011; Etkin, Prohaska, Harris, Latham, & Jette, 2006). The only apparent adverse 
outcome in CHIP was the increase of participants who reduced their HDL, which has also 
been seen throughout other CHIP research and other plant-based, vegan health programs. 
Although its implications are disputed, a reduction is not considered a detriment when 
switching to a plant-based diet (Barnard, 1991; Esselstyn et al., 1995; Kent et al., 2013b; 
Kent et al., 2015; Morton et al., 2013; Ornish et al., 1998; Rankin et al., 2012), or when 
accompanied by a normal LDL (Bartlett et al., 2016).  
The social ecological model (Bronfenbrenner, 1979) depicts how the Adventist 
health message has influenced the five social levels of society: individual, intrapersonal, 




intrapersonal, and community. The five social levels have a greater effect on an 
individual’s health outcomes when combined and accumulated (Raingruber, 2014, p. 64). 
Targeting one specific social level about health would not be as effective as 
simultaneously concentrating on multiple health factors considering healthy and 
unhealthy lifestyle principles come from each social level in reciprocal influences 
(Raingruber, 2014, p. 64) and may be indicative of research outcomes in this study. 
This research supports positive social change by showing that CHIP is a valuable 
contributor and model program for improving chronic health indicators for all people, 
regardless of Adventist affiliation. This study contributed original knowledge to the 
existing CHIP literature by extending the population’s characteristics to add a specific 
disease process, comparing a specific faith affiliation, and adding covariates. The 
variables and population characteristics of the present study were not unlike previous 
CHIP studies, thus it contributed additional empirical evidence to the field. 
Limitations of the Study 
Several limitations of this study were present. First, there was a lack of a control 
group, which limits the generalization of the results of this study. However, Rockford 
CHIP, the professional division of CHIP, has published research using randomized 
clinical control trials, with results showing similar positive outcomes as the volunteer 
division (Aldana et al., 2005a; Aldana et al., 2005b; Merrill, Taylor, & Aldana, 2008).  
Second, diet, exercise, and medication diaries were not obtained from CHIP 
participants, so it was unknown as to how much change there was to these variables, and 




facilitators that they had either reduced or removed their medications by doctor’s order 
and made other lifestyle changes (Rankin et al., 2012). Had this data been factored into 
the results, it would have only produced a diluted effect considering diet, exercise and 
medications have direct effects on the biometrics used in this study. Factoring out these 
variables would only strengthen the results. Other variables not captured but may have 
contributed to the outcome of this study include race, social and church support, income, 
and readiness to learn; thus, the influence of these variables in this study were also not 
possible to measure. 
Third, participants were self-identified in diabetes state, Adventist affiliation, and 
class participation. Participants were asked on the Lifestyle Questionnaire, “Have you 
ever been told by a doctor you have diabetes?” Therefore, they were self-identified, and 
their diabetes state or type was not verified. It is possible that those with gestational 
diabetes, type 1, or 1.5 (as opposed to type 2 diabetes that the present study focused on) 
may have been included in the self-identification. Considering that 90-95% of people 
with diabetes have type 2 (ADA, 2016), the number of other types of diabetes likely 
would have been very negligible. There were also 86 children in the population group, 
but none were listed as having diabetes.  
It is also possible that participants may have not accurately checked their 
Adventist status. Membership verification was not clarified, nor was the option to mark 
Adventist or non-Adventist defined. Some participants who marked their Adventist 
affiliation may have had loose associations with the church and others may have been 




Participants were also self-selected to participate in the CHIP program, and may have 
been more motivated, ready, and willing to make the necessary changes to a plant-based 
diet (Bartholomew et al., 2006, p. 110-113). 
Lastly, original CHIP data were input into the CHIP online databank by the local 
facilitators and a cleaned up data set shared for this research; it is unknown if errors 
occurred during data entry at any point. Considering other CHIP outcomes are all similar, 
this again suggests that such errors, if they existed, had a negligible effect. Further 
limitations and biases would have been minimal, since this research used secondary data, 
and the trial planning and trial implementation had already occurred.      
Recommendations 
CHIP is an effective 30-day lifestyle modification program in reducing chronic 
disease risk factors in both Adventists and non-Adventists with diabetes. However, 
Adventist affiliation influenced participants significantly pre- and post-CHIP. Further 
research recommendations include:   
• additional studies comparing Adventists and non-Adventists in other 
disease processes  
• investigating further the reduction of HDL in those switching to a plant-
based diet and incorporating those things into the program which are 
known to have a positive effect on HDL such as omega-3, DHA, and ALA 
supplementation 
• using a control group with the volunteer leg for broader generalizations 




• validating diabetes state per ADA standards by a glycohemoglobin A1c or 
two FPG tests (ADA, 2016) 
• comparing those who self-identify themselves as having diabetes on the 
health questionnaire and the single FPG obtained preprogram 
• incorporating an additional teaching session which focuses on trust in God 
as part of the Adventist health message and compare outcomes with a 
control group 
• questioning how long the Adventists have been a baptized member to 
compare outcome differences among themselves 
Implications for Practice 
Since the mid-1800s, the Adventist health message has been a source of 
inspiration, optimism, strength, and guidance for those facing a variety of health 
challenges without the use of medications. This message, as presented through CHIP, 
advocates a nonmedical, lifestyle approach to improve disease outcomes for people 
regardless of faith affiliation. The foundational causes, as well as treatment for managing 
and reversing type 2 diabetes, are diet and lifestyle, but these factors are often given little 
attention over Western medicine’s dietary approach and its costly, often ineffective, 
pharmaceutical approaches, which are often prescribed despite their side effects (Graham 
et al., 2010; Kannan et al., 2016; Lincoff, Wolski, Nicholls, & Nissen, 2007; Solomon & 
Winkelmayer, 2007). CHIP is a desired program for those who want a natural approach 
to diabetes prevention and reversal without the use of pharmaceuticals. The positive 




(Kent et al., 2015), those with type 2 diabetes may also attend CHIP, apply the principles 
to their own lives, and expect to see similar improvements. 
Considering the strong educational component of CHIP, as well as its solid, 
scientifically researched foundation, and the fact that the program does not demand 
adherence to an Adventist ideology (and provides limited spiritual teaching in general 
because it targets a more secular community), introducing this program in places that care 
for those with chronic disease may be beneficial. Incorporating CHIP into hospitals, long-
term care facilities, prisons, and other large and small institutions, workplaces, and the 
home setting may be effective in reducing both morbidity and mortality due to chronic 
disease, as well as realizing a substantial cost benefit (Leung et al., 2015). Considering 
that religion plays a role in health and healing (McKenzie, Modeste, Marshak, & Wilson, 
2015; Snowdon et al., 1982), and trusting in God is an Adventist health principle, it is 
reasonable to investigate whether a more focused spiritual approach affect health 
outcomes. Additional research using a control group with trusting in God as an additional 
teaching module may prove beneficial.      
Conclusion 
This chapter contained the analysis interpretation of comparing Adventists and 
non-Adventists with diabetes pre- and post-CHIP intervention, a volunteer-facilitated, 
plant-based, community health program to improve chronic disease risk factor outcomes. 
The diabetes rate was also discussed between the two groups. MANOVA, logistic 




Over the past many decades, much research has been published and dedicated to 
assessing a plant-based, vegan diet as an intervention to reverse and prevent type 2 
diabetes. Counsel on this lifestyle has been given since the time of Hippocrates and 
progressively throughout the Adventist movement for the past almost 160 years. A 
whole-foods, vegan diet is a viable prescription for individuals with diabetes willing to 
follow such a plan especially if they desire a pharmaceutical-free approach. The results of 
this study add empirical data to the existing literature, which shows the need for a 
paradigm shift in treating diabetes. A positive social change begins at any of the five 
levels of society and can have a spreading and pervasive influence as seen with the 
spread of the Adventist health message going worldwide and depicted through the SEM.  
This study has shown that both Adventists and non-Adventists with diabetes 
benefit from applying CHIP’s nutrient-dense, whole-food, plant-based dietary principles, 
but more so for non-Adventists in LDL and TC. Overall, both groups improved in all 
areas. A diet high in plant foods without the additional use of animal products, coupled 
with other practical and timeless lifestyle principles, is an effective means to improve 
biometric outcomes for those with type 2 diabetes. Programs such as CHIP are needed at 
a time when chronic disease is at an all-time high, and will be necessary to expand this 
and other similar programs if there is to be a reduction in chronic disease rates, not only 
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